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 Hyaluronic acid (HA) is a naturally occurring biodegradable polymer with a 
variety of applications in medicine including tissue engineering, dermatological fillers, 
and viscosupplementation for osteoarthritis treatment. The cytotoxicity of crosslinking 
techniques for scaffold fabrication and the high viscosity of viscosupplements have been 
issues impeding the development of products from HA. Thus, novel HA biomaterials for 
tissue engineering and improved properties of viscosupplements are in demand. 
Nanotechnology can be a useful tool to address these needs. The aim of this dissertation 
was to synthesize HA nanoparticles and use the fabricated nanoparticles to develop 
colloidal systems for these proposed biomedical applications. First, nanoparticles were 
successfully synthesized using a technique free of an oil and surfactant. Nanoparticles 
then were employed to develop colloidal gels and suspensions. Several methods were 
used to characterize nanoparticles, colloidal gels, and colloidal suspensions including 
dynamic light scattering, uniaxial compression testing, and rheometry. Factors such as 
polymer type, concentration of polymer, and molecular weight of polymer (17, 741, and 
1500 kDa) influenced nanoparticle properties. In addition, mixing nanoparticles 
composed of 17 kDa HA in deionized water at different concentrations (15%, 30%, and 
45% w/v) formed a stable 3-D colloidal gel as a result of physical entanglement of free 
polymer chains on the surfaces of nanoparticles. Mechanical and rheological 
investigation showed that Young’s modulus, shear modulus, viscosity, and viscoelasticity 
of colloidal gels are concentration dependent. These investigations also indicated that the 
colloidal gels had recoverable and dynamic properties. Viscous suspensions were also 
formed via addition of nanoparticles (17kDa or 1500 kDa) to either deionized water or to 
hyaluronic acid solution (1500 kDa). Rheological investigations showed that the viscosity 
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and the viscoelasticity of the suspensions can be controlled via interactions between 
polymer in solution and free polymer chains on the surfaces of nanoparticles. These 
interactions were shown to be influenced by type of the nanoparticles (17 kDa or 1500 
kDa). Overall, a variety of HA nanoparticle formulations were discovered that enable 
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Chapter 1: Introduction 
1.1. Introduction to hyaluronic acid 
 Hyaluronic acid (HA), also named hyaluronan, is a high molecular weight (105-
10
7 
Da) naturally occurring biodegradable polymer. HA is an unbranched non-sulfated 
glycosaminoglycan (GAG) composed of repeating disaccharides (β-1,4-D-glucuronic 
acid (known as uronic acid) and β-1,3-N-acetyl-D-glucosamide) (Figure 1-1) (1, 2). HA 
can include several thousand sugar molecules in the backbone. HA is a polyanion that 
can self-associate and that can also bind water molecules (when not bound to other 
molecules) giving it a stiff, viscous quality similar to ‘Jello’ (3).  
 
 
Figure (1-1) Chemical structure of two glycosaminoglycans (GAGs) made of 
disaccharide repeats of N-acetylglucosamine and glucuronic acid. (A) Hyaluronic acid 
(HA). (B) Chondroitin sulfate (CS). 
 
Hyaluronic acid is one of the major elements in the extracellular matrix (ECM) of 
vertebrate tissues. It is found in almost all body fluids and tissues, such as the synovial 
fluid, the vitreous humor of the eye, and hyaline cartilage (Table 1-1) (4-7). This 
biopolymer works as a scaffold, binding other matrix molecules including aggrecan (2). It 
is also involved in several important biological functions, such as regulation of cell 
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adhesion and cell motility, manipulation of cell differentiation and proliferation, and 
providing biomechanical properties of tissues (5). Several cell surface receptors such as 
CD44, RHAMM, and ICAM-1 interact with HA influencing cellular processes including 
morphogenesis, wound repair, inflammation, and metastasis (8-11). Moreover, HA is 
responsible for supporting the viscoelasticity of biofluids (synovial fluid and vitreous 
humor of the eye) and controlling tissue hydration and water transport (3). In addition, 
HA has been found during embryonic development, suggesting materials composed of 
HA may persuade favorable conditions for tissue regeneration and growth (Table 1-1) 
(12-16). 
 
Table (1-1) Examples of body tissues/fluids that contain HA. Table was regenerated with 
permission (2, 17). 




Umbilical cord 4100 Primary high molecular weight HA. 
Joint (synovial) fluid 1400-3600 
Decreasing HA concentration occurs due to increasing the synovial fluid volume 
under inflammatory conditions. 
Vitreous body 140-500 During tissue maturation, HA concentration increases. 
Cartilage - HA works as a scaffold for the binding of other matrix molecules such as aggrecan. 
Dermis 200-500 HA is used as a “rejuvenating” agent in cosmetic dermatology. 
Epidermis 100 High HA concentration was observed around the cells that synthesized dermis. 
Thoracic lymph 0.2-50 HA molecular weight affects inflammatory response and cell binding. 
 
HA’s characteristics including its consistency, biocompatibility, and 
hydrophilicity  have made it an excellent moisturizer in cosmetic dermatology and skin-
care products (3). Moreover, its unique viscoelasticity and limited immunogenicity have 
led it to be used in several biomedical applications such as viscosupplementation in 
osteoarthritis treatment, as a surgical aid in ophthalmology, and for surgical wound 
4 
 
regeneration in dermatology (3, 4). In addition, HA has currently been explored as a drug 
delivery agent for different routes such as nasal, pulmonary, ophthalmic, topical and 
parenteral (3, 18). 
 
1.1.1. History of hyaluronic acid 
 In 1934, Karl Meyer and his colleague John Palmer were the first investigators 
who discovered and isolated HA from the vitreous body of cows’ eyes (2, 3). In the 
1950s, the chemical structure of HA was solved by this group. They found that HA is 
composed of two sugar molecules (D-glucuronic acid (known as uronic acid) and D-N-
acetyl glucosamine) and called it hyaluronic acid (hyaluronan). This name is derived 
from “hyalos” (the Greek word for glass + uric acid). Initially, they isolated HA as an 
acid but it behaved like a salt in physiological conditions (sodium hyaluronate) (2-4). At 
the time, they did not fully appreciate their discovery of one of the most interesting and 
important biological macromolecules. Several years after them in 1942, Endore Balazs 
patented the first application of HA as a substitute for egg white in bakery products (3). 
 The first biomedical application of HA took place in late 1950s when HA was 
used for a vitreous substitution/replacement during eye surgery. For medical applications, 
HA was initially isolated from umbilical cord and shortly afterward, from rooster combs 
(3, 4). Later on, HA was isolated from other sources and the structural/biological 





1.1.2. Properties of hyaluronic acid 
1.1.2.1. Chemical properties of hyaluronic acid 
 Structural studies showed that the two sugar molecules, D-glucuronic acid and D-
N-acetyl glucosamine, in the HA disaccharide structure are connected together through 
alternative beta-1,4 and beta-1,3 glycosidic bonds (Figure 1-1) (2, 3). The hyaluronic acid 
backbone is stiffened in physiological solution via a combination of internal hydrogen 
bonds, interactions with solvents, and the chemical structure of the disaccharide. HA 
molecular investigations suggested that the axial hydrogen atoms form a non-polar face 
(relatively hydrophobic) and the equatorial side chains form a more polar face 
(hydrophilic) led to a twisted ribbon structure for HA called a coiled structure (3).  
 HA’s structural characteristics hinge on this random coiled structure in solution. 
At very low concentrations, chains entangle each other, leading to a mild viscosity 
(molecular weight dependent). On the other hand, HA solutions at higher concentrations 
have a higher than expected viscosity due to greater HA chain entanglement that is shear-
dependent. For instance, a 1% solution of high molecular weight HA (Mw > ~1000 kDa) 
can behave like jelly, but when shear stress is applied it will easily shear thin and can be 
administered via a thin needle (3). As such, HA is known as a “pseudo-plastic” material. 
This rheological property (concentration and molecular weight dependent) of HA 
solutions has made HA ideal for lubrication in biomedical applications (3). 
 In addition to the unique viscosity of HA, viscoelasticity is another characteristic 
of HA resulting from entanglement and self-association of HA random coils in solution 
(2). It was suggested that the molecular self-association of HA occurs by forming anti-
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parallel double helices, bundles and ropes. Further experiments verified that HA chain–
chain association occured in solution. Moreover, studies proposed that hydrogen bonding 
between adjacent saccharides occurred alongside mutual electrostatic repulsion between 
carboxyl groups, thus stiffening HA (3, 6, 19). Viscoelasticity of HA can be tied to these 
molecular interactions which are also dependent on concentration and molecular weight.  
 Electrostatic and ionic effects on HA were evaluated as a function of counter-ion 
type and valency. Studies suggested that these greatly affect rheological and 
hydrodynamic properties of HA. In one study, the effect of electrostatic and ionic 
interactions was investigated by comparing HA solution properties in deionized water 
(D.I.), 0.5 M NaCl, and 0.5 M NaOH. This study showed that solution properties affect 
the hydrogen bonding and electrostatic interaction between the solution and HA resulting 
in a change in HA chain stiffness (2, 20). Moreover, the hydrodynamic radius of HA was 
found to be greater in D.I. water than in 0.5 M NaCl or 0.5 NaOH (D.I. water > 0.5M 
NaCl > 0.5M NaOH) (2). 
 
1.1.2.2. Biological properties of hyaluronic acid 
 As mentioned before, hyaluronic acid performs several structural tasks in the 
extracellular matrix (ECM) as it binds with cells and other biological components 
through specific and non-specific interactions. Several extracellular matrix proteins are 
stabilized upon binding to HA. Specific molecules and receptors that interact with HA are 
involved in cellular signal transduction; molecules such as aggrecan, versican, and 
neurocan, and receptors including CD44, RHAMM, TSG6, GHAP, and LYVE-1 are 
examples of cell components that bind to HA (3). Between these receptors, CD44 and 
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RHAMM seem to have received more attention since they are found to be involved in 
cancer metastases (3, 21-23). CD44 is a structurally variable and multifunctional cell 
surface glycoprotein on most cell types and is perhaps the best characterized 
transmembrane HA receptor so far. Due to its wide distribution and based on current 
knowledge, CD44 is considered to be the primary HA receptor on most cell types (3, 24). 
 Hyaluronic acid also stimulates gene expression in macrophages, endothelial 
cells, eosinophils, and certain epithelial cells. High molecular weight HA does not seem 





 Da) is known to promote gene expression (3, 25, 26). As an example, HA 
is also known to have an important role in wound healing and scar formation. Products of 
HA degradation (low molecular weight HA) are identified to contribute in the scar 
formation process. Moreover, scar formation was minimized when high molecular weight 
HA was found in wound fluid during fetal wound healing. These results suggested that 
the molecular weight of HA plays a significant role in wound healing and scar formation. 
The findings also suggested that high molecular weight HA favored cell quiescence and 
supported tissue integrity, whereas production of HA fragments signaled injury and 




1.2. Synthesis of hyaluronic acid 
 Hyaluronic acid is a natural polymer biologically synthesized by cells in the body 
via an enzymatic process. HA production is a unique, highly controlled, and continuous 
process in which HA is produced and secreted by fibroblasts, keratinocytes, or 
chondrocytes. The Golgi network is the production site for most glycosaminoglycans. In 
tissues such as skin and cartilage where HA comprises a large portion of the tissue mass, 
the level of HA synthesis is very high. HA is naturally synthesized by hyaluronan 
synthases (HAS1, HAS2, and HAS3), a class of integral membrane proteins (3, 28). In 
HA production by hyaluronan synthase enzymes, large linear polymers of the repeating 
disaccharide units are made. The mechanism of HA synthesis involves chain extension 
by addition of a monosaccharide (alternating addition of glucuronic acid and N-acetyl 
glucosamine) to the reducing end of the chain (2). The number of repeat disaccharides in 
a completed HA molecule can reach as high as 10,000 or more and a molecular weight of 
around 4 million Daltons (molecular weight of each disaccharide is about 400 Daltons). 
Since the average length of a disaccharide is about 1 nm, a HA molecule of 10,000 
repeats could extend 10 µm if stretched from end to end (approximately equal to the 
diameter of a human erythrocyte) (3, 29). 
 
1.3. Degradation of hyaluronic acid 
 Degradation of HA is a step-wise process that can occur via enzymatic or non-
enzymatic reactions. Three types of enzymes (hyaluronidase, β-D-glucuronidase, and β–
N-acetyl-hexosaminidase) are involved in enzymatic degradation of hyaluronic acid. 
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These enzymes are found in various forms, in the intercellular space and in serum. 
Hyaluronidase cleaves high molecular weight HA into smaller fragments while the other 
two enzymes degrade the fragments by removing non-reducing terminal sugars (3, 17, 
30). It was observed that cleavage can occur in a single glycosidic bond on the HA 
backbone causing fragmentation or the enzyme can remove a single monosaccharide unit 
from the HA backbone (30). Enzymes not only help to degrade HA but also play an 
important role defining HA. For instance, enzymes available in the cytosol of cells are 
involved in basic biological processes including trimming of oligosaccharides (30).  
 Non-enzymatic mechanisms often degrade HA via thermal or shear stress. In 
addition, chemical reactions such as acidic/alkaline hydrolysis and degradation by 
oxidants are categorized as non-enzymatic degradation pathways for HA (17, 30, 31). 
Ultrasonication degrades HA in a non-random fashion. Studies suggested that high 
molecular weight HA chains degrade slower than low molecular weight HA chains 
subjected to ultrasonication (2, 30). Heat is another type of stress leading to HA 
degradation. Rheological studies on HA solutions showed that increasing temperature 
resulted in degradation and decreased viscosity exponentially as a function of 
temperature (30). 
 Similar to other polysaccharides, acid and alkaline conditions can hydrolyze HA. 
This type of degradation occurs in a random fashion often resulting in disaccharide 
fragment production. Acidic hydrolysis degrades the glucuronic acid moiety. On the 
other hand, alkaline hydrolysis occurs on N-acetylglucosamine units (30). HA can also 
degrade via oxidation. Reactive oxygen species (ROS) can be generated from cells as a 
consequence of aerobic respiration. Superoxide anions, hydroxyl radicals, and 
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hypochloride are examples of these species that cause HA chain cleavage. ROS are 
proposed to be involved in several inflammatory and biodegenerative processes such as 
arthritis but their mechanism of action in the disease are myriad and still largely unknown 
(2, 30). 
 
1.4. Turnover and possible pathways for elimination of hyaluronic acid 
 Studies showed that the concentration of HA in the human body varies from a 
high concentration of 4 g/kg in umbilical cord, 2-4 g/L in synovial fluid, 0.2 g/kg in 
dermis, and about 10 mg/L in thoracic lymph, to a low concentration of 0.1-0.01 mg/L in 
normal serum. In a normal human body (70 kg), the total HA body content is 
approximately 15 g (2, 3). From this 15 g, the largest amount was found in the 
extracellular matrix (ECM) of skin and musculoskeletal tissue. Depending on the location 
of HA in the body, most of the HA is catabolized within days. Studies suggested that the 
normal half-life of HA varies from 1-3 weeks in inert tissues such as cartilage, 1-2 days 
in the epidermis of skin, to 2-5 minutes in blood circulation. Besides enzymatic 
degradation and non-enzymatic degradation pathways described previously, two more 
pathways are engaged in HA catabolism: turnover (internalization and degradation within 
tissue) and release from the tissue matrix, drainage into the vasculature, and clearance via 





Figure (1-2) HA catabolic pathway in the body. Arrows show the flow of HA. 
Concentration (c), half-life (t1/2), and molecular weight (Mw) of HA within the organ 
systems are indicated. Figure was regenerated with permission (2). High Mw > ~1000 
kDa and low Mw < ~450 kDa. 
  
 In structural tissues like bone or cartilage with no or little lymphatic drainage, HA 
degradation occurs in situ with other ECM molecules such as collagens and 
proteoglycans. On the other hand, in skin and joints, a minimal fraction (approximately 
20-30%) of HA degrades in situ. Approximately, 50% of HA in the body is available in 
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skin tissue. Since HA is restricted to the small intracellular space of skin tissue, its half-
life is a bit longer at days and weeks (2, 17). 
 HA can also be eliminated through the lymphatic system draining the 
extracellular space of relatively dense tissues. First, high molecular weight HA is 
partially degraded before it releases from the tissue matrix. Upon release from the tissue 
matrix, degraded HA enters the lymphatic system. HA metabolic degradation mostly 
takes place in the lymphatic system as HA goes through peripheral tissues to the blood 
circulation (2). One of the functions of the lymphatic system is to collect filtered plasma 
and interstitial fluid and transport them back to the blood circulation. Studies showed that 
most of the subcutaneously injected radio-labeled HA is picked up and degraded in 
lymphatic tissue (2, 17). Remaining HA enters into the blood circulation and is rapidly 
removed in the liver by sinusoidal endothelial cells or eliminated via kidneys. In the 
blood circulation, the liver eliminates about 80% of HA and kidneys clear 10% of HA 
from bloodstream (Figure 1-2).  As mentioned before, the daily turnover of HA is on the 
order of one-third (5 g) of the total HA body content (15 g) (2). 
 Synovial fluid is one of the body fluids containing high molecular weight HA. 
Lubrication and viscoelasticity are properties of high molecular weight HA in synovial 
fluid. In a healthy joint, high levels (2-4 g/L) of HA with high molecular weight 
(approximately 6-7 MDa) are required for synovial fluid to function properly. In order to 
have synovial fluid lubrication and viscoelasticity, macromolecules including HA are 
secreted by synoviocytes continuously into the synovial fluid. Every time pressure is 
increased, fluid is pushed out of the joint cavity into micro-capillaries embedded in the 
synovium. Therefore, HA escapes through the interstitial drainage pores in the synovial 
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lining (diameter 30-90 nm). It is also suggested that high molecular weight HA can form 
a layer at the tissue-fluid interface forming a “shell” that is not drained into micro-
capillaries. The normal intra-articular turnover time for HA is found to be less than 40 
hours. Both HA molecular weight and concentration are decreased in patients with 
arthritis resulting in a significant reduction in synovial fluid functionality. Moreover, 
studies showed that production and secretion of ROS in arthritic joints degraded the HA 
in synovial fluid and cartilage (2, 3, 32-34). 
 
1.5. Biomedical application of hyaluronic acid 
1.5.1. Application of hyaluronic acid in tissue engineering 
 Since hyaluronic acid is one of the main components of body tissues, its potential 
for tissue engineering applications has been highly touted. HA is highly soluble at room 
temperature and has a high rate of elimination and turnover depending on its molecular 
weight and location in the body. Each of these properties could be a barrier for HA 
scaffold fabrication and structural integrity. To overcome these limitations, crosslinking 
of hyaluronic acid has been proposed (4, 35, 36). Currently, water-soluble carbodiimide 
crosslinking (37), polyvalent hyadrazide crosslinking (38), divinyl sulfone crosslinking 
(39), disulfide crosslinking (40), and photocrosslinking of hydrogels through glycidyl 
methacrylate-HA conjugation (41) have been introduced for tissue engineering 
applications of HA. Chemical crosslinking of HA provides the ability to combine the 
desirable biological and mechanical properties, even for bone or cartilage tissue 
engineering (4, 35). Moreover, crosslinking extends the HA degradation process in vivo 
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and provides long-term stability. Crosslinking HA at various densities has been used for 
multiple applications including orthopedics, cardiovascular medicine, and dermatology 
(35). 
 Studies have suggested positive results for cell growth on photocrosslinked HA 
networks incorporated with chondrocytes. Chondrocytes within the HA hydrogel retained 
viability and were able to generate cartilage within the porous network (35, 42). This type 
of photopolymerization has also been used in heart valve applications to mimic cardiac 
valve development (21). HA has also been combined with other polymers such as 
polypyrrole to develop multifunctional copolymers. HA functionalized with polypyrrole 
is electronically conductive and supports cell growth. This copolymerization could have 
potential for tissue engineering applications (43, 44). Benzyl derivatives of HA is another 
category of polymeric scaffolds used for tissue engineering of cartilage with predictable 
degradation rates. Studies on these derivatives suggested the potential of benzyl esters of 
HA as a delivery scaffold for chondrocytes in cartilage tissue engineering (35, 45). Since 
HA is a biocompatible natural polymer, development of scaffolds based on HA appears 
to be suitable for surfaces contacting blood. For example, HA crosslinked with divinyl 
sulfone (DVS) in the presence of ultraviolet light has been suggested to develop “non-
activating” surfaces for cell adhesion in heart valve tissue engineering (35, 46, 47).  
 Auto-crosslinked and in situ crosslinked HA hydrogels are another category of 
crosslinking used for tissue engineering. The requirement for surgical implantation is the 
major limitation of most scaffolds used for tissue engineering. Application of HA that 
crosslinks after injection has been introduced for three main reasons. First, the injectable 
HA could be filled into any desirable shape and crosslinked in situ. Second, crosslinkable 
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HA may adhere to the native tissue resulting in mechanical or chemical interlocking and 
a cohesive scaffold-tissue interface. Third, injection and laparoscopic methods can be 
used to reduce the invasiveness of the surgical procedure (48). Studies showed that in situ 
crosslinked HA hydrogel using adipic acid dihydrazide and aldehyde chemistry could 
form a flexible hydrogel in situ upon mixing (49). In another study, poly(lactic-co-
glycolic acid) nanoparticles were mixed with HA of similar chemistry to develop an in 
situ crosslinkable system with drug delivery potential. Although such in situ crosslinking 
has been shown to form flexible hydrogels with reasonable mechanical properties, 
potential toxicity of the reactions used in these techniques are still an important issue to 
consider (50). 
 
1.5.2. Application of hyaluronic acid as a dermal filler  
 The influence of sun exposure, gravity, and years of facial muscle movements 
starts to appear as wrinkles on the skin. During the aging process, basic changes in the 
skin, soft tissue, and skeletal support of the face occur resulting in a breakdown of the 
tissues under the skin leaving lines or other facial defects (51, 52). Skin aging can be 
divided in two categories: internal aging and external aging. 
  Internal aging of skin causes various histological changes in different skin layers 
such as flattening of the epidermal-dermal interface, a decrease in the number of 
melanocytes and Langerhans cells in the epidermis, a loss of dermal papillae, dermal 
atrophy, a decrease in the number of mast cells, fibroblasts, and blood vessels, a loss of 
elastic tissue in the fine subepidermal elaunin network, and abnormal thickening and 
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fragmentation of elastic tissue in the reticular dermis (52). Internal aging also reduces 
several skin functions such as type I and type III collagen production, the epidermal 
turnover rate, and melanocyte activity (52, 53). 
 External aging is influenced by sun exposure and UV radiation and also causes 
histological changes which are different from other changes caused by internal aging. 
External aging is typified by damage of elastic tissue and decrease in cellularity. 
Photodamage induces elastosis, the overgrowth of abnormal elastic fibers, and an 
increase in population of histiocytes, fibroblasts, and mast cells (52, 53). In both internal 
and external aging, collagen content and melanocyte activity are decreased and wound 
healing is abnormal (52). 
 To address age-related changes in skin quality and appearance, several treatments 
have been proposed (Table 1-2). Development of soft-tissue fillers (dermal fillers) can 
help lines and wrinkles to be filled temporarily (or permanently) (51). It seems an ideal 
dermal filler should be temporary but long-lasting, having minimum side effects and no 
allergenic effect, easy to administer, having minimum pain or no pain upon injection, and 




Table (1-2) Treatments proposed to enhance age-related changes in skin quality (52). 
Treatment Remarks 
Skin protections and 
skin cares 
Sunscreens help to enhance changes in skin quality and appearance caused by sun exposure. Daily skin care 
is recommended to improve the quality and appearance of aged skin.  
Chemical peels 
Chemical peels applied directly to the skin use alpha-hydroxy acid, salicylic acid, trichloroacetic acid, or 
phenol can improve the appearance of aged skin. 
Nonablative therapies 
In nonablative therapies, light or thermal energy from various sources (visible and infrared lasers, intense 
pulsed light, light-emitting diodes, and radiofrequency) are used to improve skin texture, discoloration, and 
scarring.  
Ablative therapies 
Ablative therapies are laser treatments in which the laser induces ablation of water-containing tissue 
(epidermal tissue). 
Botulium toxin type A 
injection 
Local injection of botulinum toxin causes temporary muscle denervation, resulting in relaxation of 
hyperfunctional facial muscles and smoothing of the skin overlying these muscles.  
Dermal fillers Dermal fillers are used to recover soft-tissue volume of the skin and remove skin wrinkles. 
 
 Depending on the residence time in tissue, dermal fillers are categorized as 
temporary, semipermanent (at least 18 months), and permanent. They are also classified 
based on their composition with the primary ingredients such as collagen (bovine, 
porcine, or human), animal or synthetic hyaluronic acid, poly-L-lactic acid, calcium 
hydroxyapatite, polymethyl methacrylate, and polyacrylamide gel (Table 1-2) (52, 54-
56). 
 Hyaluronic acid has been approved by the Food and Drug Administration (FDA) 
as a dermal filler. In 2006, cosmetic injections of HA were known to be the second most 
popular non-surgical procedure for women and the third most popular procedure for men 
(57-60). HA has a very short half-life and, therefore, is chemically crosslinked to extend 
duration as a dermal filler (61). HA is not involved in the structure of collagen and does 
not enhance tissue, the shortage of HA, in aged skin, but simply works by augmenting 
volume (51, 57). The development of dermal filler products with enhanced injectability 
and longer duration is desired.  
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Table (1-3) Different types of dermal fillers and some of the commercially available 
products (52, 54, 56, 59). 
Material Brand name Description Duration Biodegradability 
Autologous fat Viable Fat - Temporary Biodegradable 
Hyaluronic acid 
Restylene® Cross-linked HA (20 mg/mL) Temporary 6-12 months 
Biodegradable 
Prelane® Cross-linked HA (20 mg/mL) Temporary 6-12 months 
Juvéderm® Cross-linked HA (24 mg/mL) Temporary up to 12 months 
Elevess® Cross-linked HA (28 mg/mL) Temporary months 
Hylaform® Cross-linked HA (5 mg/mL) Temporary 3-6 months 
Collagen 
Zyderm® 3.5% bovine collagen+0.3% lidocaine Temporary 3-4 months 
Biodegradable 
Zyplast® 
3.5% crosslinked bovine collagen 
+0.3% lidocaine 
Temporary 3-6 months 
CosmoDerm® 3.5% human collagen+0.3% lidocaine Temporary 3-5 months 
CosmoPlast® 
3.5% crosslinked human 
collagen+0.3% lidocaine 
Temporary 3-5 months 
ArteFill® 
20% PMMA microsphers+80% bovine 
collagen (3.5%)+0.3% lidocaine 




Calcium hydroxyapatite microspheres 
in aqueous gel 
Semipermanent 2-5 years Biodegradable 
Poly-L-lactic acid Sculptra
® 
Injectable PLLA microspheres 








Atlean® - Semipermanent Biodegradable 
Polyacrylamide gel 
Aquamid® 












Silicone - Permanent Not biodegradable 
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1.4.3. Application of hyaluronic acid in osteoarthritis treatment 
 Osteoarthritis (OA) is the most common disease associated with aging, affecting 
approximately 33 million Americans with about 70% of these individuals aged 65 and 
over. OA is characterized by the slow degradation of cartilage, pain, and increasing 
disability. The disease can have an impact on several aspects of a patient’s life, including 
functional and social activities (62, 63). Current pharmacological therapies target 
palliation of pain and include analgesics (i.e. acetaminophen, cyclooxygenase-2-specific 
inhibitors, non-steroidal anti-inflammatory drugs, tramadol, opioids), intra-articular 
therapies (glucocorticoids and hyaluronan), and topical treatments (i.e. capsaicin, 
methylsalicylate). If none of these therapies work, surgical joint replacement is the last 
option, which is costly and highly invasive (63). 
 Synovial spaces are the cavities of the joints that facilitate movement of adjacent 
bones. Synovial spaces are formed by a surface of cartilage, synovium, and synovial 
fluid. The synovial fluid is a clear, colorless or sometimes yellowish liquid secreted into 
the joint cavity by the synovioum. The synovial fluid volume is approximately 2 mL in 
normal human knee joints and contains electrolytes, low molecular weight organic 
molecules, and macromolecules such as glycosaminoglycans (GAGs). GAGs present in 
the synovial fluid are chondrotin-4-sulfate (2%), with the remaining 98% made up of HA 
(62). 
 The mechanical function of the synovial fluid can be attributed to its rheological 
properties, more specifically its viscoelastic properties. Synovial fluid viscoelasticity may 
be ascribed to the concentration, molecular weight, and molecular weight distribution, 
and to the physical and non-covalent interactions within the HA molecule as well as with 
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other molecules such as proteins and ions (4). HA molecules overlap and interact though 
physical entanglement or temporary crosslinking interactions with ions and proteins at 
physiological conditions. These interactions, which are dependent on HA molecular 
weight and concentration, determine the formation of the transient network structure that 
is responsible for the viscoelasticity of synovial fluid (62, 63). In OA, HA loses these 
functionalities as a result of reduced HA molecular weight and concentration; thus, 
decreasing the viscoelastic properties of synovial fluid (32, 62, 64). 
 The viscoelastic behavior of synovial fluid can be described by the elastic 
modulus (Gˊ) and viscous modulus (G˝) as a function of frequency (32, 65, 66). The 
degradation of synovial fluid is evident from its rheological properties. Generally, aging 
is the main reason for a reduction in HA molecular weight or HA concentration (Table 1-
4). After damage or aging, synovial fluid cannot provide the required viscoelastic 
response to compression and tangential forces arising in everyday life, allowing cartilage-
cartilage contact and increasing wear of the joint surface (62, 63). Intra-articular 
treatment with HA and hylans (uncrosslinked HA and crosslinked HA, respectively) has 
recently been accepted as a common therapy for reducing pain associated with OA (62, 




 (HA) and 
Synvisc
®
 (hylan GF 20) are available as viscosupplements for intra-synovial injection in 













Zero shear viscosity 
(Pa.s) Elastic  modulus (G') 
(Pa)  at 2.5 Hz 
Viscous modulus 
(G'') (Pa)  at 2.5 Hz 
Healthy  Young 
Synovial Fluid 
6.3-7.6 2.5-4 23 7 6-175 
Osteoarthritic 
Synovial Fluid 
1.6-3.48 1-2 7 5 0.01-1 
 
Table (1-5) Some of the HA viscosupplements available in the North American market. 










(Hyaluronic acid, 2%) 
1000 1 injection 3 Knee or hip, mild or moderate 
Fermathron® 
(Sodium hyaluronate, 1%) 
1000 3-5 injections 2 Knee, mild or moderate 
Hyalgan® 
(Sodium hyaluronate, 1%) 
500-730 3-5 injections 2 Knee, shoulder, or hip 
NeoVisc® 
(Sodium hyaluronate, 1%)  
1000 3-5 injections 2 
Synovial fluid replacement 
following arthrocentesis 
Orthovisc® 
(Sodium hyaluronate, 1.4%) 
1000-2900 3 injections 2 Knee 
Ostenil® 
(Sodium hyaluronate, 1%) 
1000-2000 3 injections 2 
Degenerative or traumatic 
synovial joint disorders, 
including knee joint 
Supartz® 
(Sodium hyaluronate, 1%) 
620-1170 3-5 injections 2.5 
Knee nonresponsive to 
conservative therapy 
Suplasyn® 
(Sodium hyaluronate, 1%) 
500-730 3-6 injections 2 
Synovial fluid replacement 
following arthrocentesis 
Synvisc® 
(Hylan G-F 20; Crosslinked 
HA) 
6000-7000 3 injections 2 
Knee nonresponsive to 0.8% 
conservative therapy 
* The number of weekly intra-articular injections per treatment course, excluding 
Durolane
®
, which is given as a single injection. 
 
 Several clinical trials have demonstrated the efficacy and tolerability of intra-
articular HA for the treatment of pain associated with OA. These studies have shown 
three injections of Synvisc
®
 (crosslinked HA) can provide relief of knee pain up to 6 
months. A competing product, Hyalgan
®
 (sodium hyaluronate solution), requires 6 
injections to reach the same efficacy of Synvisc
®
 (34, 67, 72, 73). While Synvisc
®
 was 
shown to be more efficient in reducing pain, its structure (high molecular weight HA due 
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has a lower viscosity, making injection easier, but Hyalgan
®
 is not as effective as 
Synvisc
®
 due to lower viscoelastic properties (elastic and viscous moduli)  (65, 67, 73). 
Moreover, Orthovisc
®
, one of the viscosupplements with the highest HA concentration, 
has lower viscosity than Synvisc
® 
but it is not reported to be as effective as Synvisc
®
 (65, 
67, 73). This creates a need for development of products with enhanced injectability and 
yet reasonable viscoelastic behavior (Synvisc
®
 elastic and viscous moduli values). 
 









 product information, Synvisc
®
 product information, and 








Duration of pain 
relief Elastic modulus (G') 
(Pa) at 2.5 Hz 
Viscous modulus (G'') 
(Pa) at 2.5 Hz 
Hyalgan® 
(Uncrosslinked) 
500-730 0.6 3 3-5 6 months 
Orthovisc® 
(Uncrosslinked) 









1.6. Introduction of thesis 
 Due to the prevalence of hyaluronic acid in the body, HA has been deemed as a 
suitable material for biomedical applications. Three applications of HA were introduced; 
tissue engineering, dermal filling, and viscosupplementation. In each application, 
difficulties such as potential toxicity of in situ crosslinking techniques, high viscosity of 
HA solutions, and rapid elimination have been raised as limitations to develop 
biomedical products from HA. Nanotechnology may provide an approach to resolve these 
limitations. Studies suggested that fabrication of nanoparticles from polymers can effect 
bulk properties (physical, mechanical, rheological, and etc.) of ensuing materials (74, 75). 
In this work, a nanoparticle fabrication technique for HA has been introduced. Then, the 
use of HA nanoparticles to modify viscosity and viscoelasticity of HA solutions or 
suspensions was explored. This study is focused on the application of HA nanoparticles 
to develop materials for tissue engineering, dermal filling, and viscosupplementation. 
 As mentioned, crosslinking is a common technique employed for HA scaffold 
fabrication. Almost all of the crosslinking reactions used for this purpose are toxic to 
cells; however, the desired mechanical properties can be achieved for tissue engineering 
applications (18, 63). In addition to that, injectability of viscous HA is another desired 
property that can help physicians to fill a defect site without invasive surgery (5, 49). 
This thesis aimed to develop a new type of colloidal material based on HA nanoparticles, 
which can be used as a self-assembled scaffold without utilizing chemical reactions. The 
injectability of the colloidal material and its behavior under shear stress was evaluated to 
determine applicability as an injectable scaffold for tissue engineering. 
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 HA nanoparticles may also be used to enhance the properties of dermal fillers. 
HA based dermal fillers are one of the most popular for temporary treatment within a 
duration of up to 12 months (52, 54, 56). These crosslinked HA solutions are viscous and 
difficult to administer with fine needles. Modifying these supplements with HA 
nanoparticles may extend the residency of the HA in vivo and increase the treatment 
duration to more than 12 months. Moreover, nanoparticles may also help to reduce the 
viscosity of these solutions for easy injection via fine needles. In this thesis, HA 
nanoparticles were used to modify HA polymer solutions and the effect on viscosity was 
evaluated. 
 Modification of viscosupplements used for osteoarthritis treatment is another area 
in which HA nanoparticles may be employed. High viscosity of viscosupplements such 
as Synvisc
®
 has always been an issue (65, 67, 68). In this research, reducing the viscosity 
of HA solutions by using HA nanoparticles was investigated. Viscoelastic behavior 
(change in elastic and viscous moduli), another characteristic of HA solutions (and 
suspensions), was evaluated to determine the effect of nanoparticles in HA solutions (and 
suspensions). An outline of the design characteristics and rationale of this thesis are 
shown in Table 1-7. 
 
Table (1-7) Outline of the design characteristics and rationale of the thesis. 
Hyaluronic acid Remarks Applications 
Polymer solution 
The viscosity of solution is high at high Mw of 
HA even at low concentrations 






Reducing the viscosity and viscoelastic properties 
(elastic and viscous moduli) compared to the 
polymer solution Dermal fillers, osteoarthritis 
viscosupplements 
Nanoparticle & Polymer 
Reducing or increasing the viscosity and 
viscoelastic properties (elastic and viscous 
moduli) compared to the polymer solution 
Nanoparticle in colloidal gel Developing 3-D HA scaffold Scaffold fabrication 
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1.7. Design of the thesis 
 The studies outlined in this thesis include nanoparticle fabrication, nanoparticle 
characterization, development of colloidal systems based on nanoparticles, and finally 
characterization of these colloidal systems including physical, mechanical, and 
rheological characterization. 
 
 Chapter 2: Fabrication of hyaluronic acid nanoparticles 
 Nanoparticles were synthesized using a technique free of oil and surfactant. In 
this method, nanoparticles were fabricated by crosslinking HA polymer chains through 
their carboxyl groups via carbodiimide chemistry (76). The crosslinking reaction was 
validated via Fourier transform infrared spectroscopy (FTIR). The effect of polymer type 
(hyaluronic acid or chondroitin sulfate), polymer concentration, HA molecular weight, 
reaction time, and the ratio between polymer to crosslinker was evaluated. To understand 
the morphology of the nanoparticles, cryo-transmission electron microscopy was used.   
 
 Chapter 3: Application of hyaluronic acid nanoparticles for colloidal gel 
 fabrication 
 HA nanoparticles (chapter 2) were used to form colloidal gels in this chapter. 
Colloidal gels were made by mixing nanoparticles with deionized water at different 
concentrations. First, the effect of the type of nanoparticles (hyaluronic acid or 
chondroitin sulfate nanoparticles), concentration of nanoparticles, and the molecular 
weight of HA used for nanoparticle fabrication was tested. Then, the swelling ratio of 
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colloidal gels was measured in deionized water and 0.1 M PBS to understand the 
behavior of colloidal gels compared to a classic HA hydrogel. Uniaxial compression 
testing was employed to evaluate mechanical properties of colloidal gels at different 
conditions. Rheological properties (viscosity and viscoelastic properties (elastic and 
viscous moduli)) of the colloidal gels were also determined. Finally, structural 
recoverability and dynamic behavior of colloidal gels were examined using uniaxial 
compression testing and rheometry. 
 
 Chapter 4: Application of hyaluronic acid nanoparticles in colloidal suspensions 
 as a potential osteoarthritis treatment 
 To evaluate the potential of HA nanoparticles for osteoarthritis treatment and the 
effect of nanoparticles on rheological behavior (viscosity and viscoelasticity) of HA, two 
experiments were designed. For both experiments, HA (HA Mw=1500 kDa) at 1.4% w/v 
was prepared as a model of the Orthovisc
®
 viscosupplement for osteoarthritis treatment 
(or dermal filler). The rheological effect of mixing HA polymer with HA nanoparticles at 
different ratios (maintaining HA concentration of 1.4% w/v) was studied. The interaction 
between nanoparticles and HA polymer was observed to affect the viscosity and 
viscoelasticity of the HA suspension. The effect of nanoparticle concentration on the 
rheological properties of HA nanoparticle suspensions was examined. Here, the effect of 
nanoparticle fabrication to reduce the viscosity of HA suspensions was explored. All the 
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Chapter 2: Fabrication of hyaluronic acid nanoparticles 
2.1. Introduction 
 Polymer nanotechnology has emerged as an important tool to successfully 
develop and modify biomaterials for drug delivery and tissue engineering. Methods have 
been developed to modify surface features and core components of nanoparticles for 
many applications (1). For instance, conjugation and optimization of targeting moieties to 
the surface of nanoparticles has been introduced to enhance targeted delivery of 
therapeutic agents to cells (2-6). Moreover, research studies have been developed to 
modify the surface of nanoparticles and fabricate biocompatible scaffold constructs for 
tissue engineering applications (7-9). In both cases, synthetic biopolymers such as 
polylactic acid (PLA), Poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) and 
natural polymers such as chitosan, alginate, and hyaluronic acid have been explored (1). 
Moreover, polymers including dextran, poloxamer (Pluronic
®
) and poly(vinyl alcohol) 
(PVA) have been used as colloid stabilizers (1). Due to discrete properties of polymers 
and varied application of nanoparticles, multiple fabrication methods have been 
developed. However, continuous development of novel nanoparticle fabrication methods 
has always been required. 
 One of the natural polymers used for nanoparticle fabrication is hyaluronic acid 
(HA). Several methods have been proposed to fabricate HA nanoparticles. Electrostatic 
interactions with positively charged polymers such as chitosan or biological components 
such as proteins have been shown to form nanoparticles. Changing suspension conditions 
such as pH and ionic strength can dissociate the polyelectrolyte systems. Therefore, these 
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types of nanoparticles may only be stable under specific conditions in which the particles 
are formed. Studies have utilized electrostatic interactions to synthesize nanoparticles via 
complexation of HA with cationic polymers and therapeutic agents for delivery of anti-
tumor drugs, treatment of asthma, and active tumor targeting (10-14). Chemical 
crosslinking has also been suggested to fabricate hydrophobic core-hydrophilic shell HA 
nanoparticles (15). Unlike electrostatic interactions, structurally stable HA nanoparticles 
can be synthesized via chemical crosslinking techniques. Not many reports are available 
for HA nanoparticle fabrication using chemical crosslinking. Techniques including water-
in-oil-emulsion processes, spray drying, and solvent evaporation have also been reported 
to make micron-scale HA particles (16); however, these studies showed that completely 
removing oil and surfactant from the HA particles is difficult. Controlling the size 
distribution of particles by spray drying can also be difficult (17). Therefore, the 
development of HA nanoparticle fabrication methods which produce relatively uniform 
and stable colloids without the use of oil and surfactant is desirable (17). 
 A technique free from oil and surfactant by Hu et al. was used to fabricate HA 
nanoparticles (17). Chemical crosslinking based on carbodiimide chemistry was used to 
synthesize nanoparticles from HA polymer. Besides hyaluronic acid, chondroitin sulfate 
(CS), another naturally occurring glycosaminoglycan (GAG), was also selected to make 
nanoparticles in this study. Dynamic light scattering was employed to evaluate the effect 
of polymer type (hyaluronic acid and chondroitin sulfate), polymer concentration, HA 
molecular weight, reaction time, and the ratio between polymer to crosslinker on the size 
and charge of nanoparticles. Then, cryo-transmission electron microscopy was used to 
understand the morphology of nanoparticles. Fourier transform infrared spectroscopy 
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(FTIR) was also employed to confirm the crosslinking reaction. Nanoparticles 
synthesized in this chapter were used in chapters three and four to understand the 
possibility of colloidal gel fabrication and the effect of nanoparticles on the properties of 
HA suspensions.  
 
2.2. Materials and Methods 
2.2.1. Materials 
 Polymers of hyaluronic acid (HA) sodium salt manufactured using an extremely 
efficient microbial fermentation process (HA with different molecular weights of 17 kDa, 
741 kDa, and 1500 kDa) were purchased from Lifecore Biomedical (Chaska, Minnesota). 
1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) was purchased 
from Thermo Scientific (Rockford, Illinois). Acetone was obtained from Fisher Scientific 
(Fair Lawn, New Jersey). Chondroitin sulfate sodium salt from bovine cartilage (Mw ~ 
30 kDa), adipic acid dihydrazide, and trinitrobenzene sulfonic acid (TNBS) (~1 M in 
H2O) were purchased from Sigma-Aldrich (St. Louis, Missouri). Dialysis membrane 
(Regenerated Cellulose (RC), MWCO 50,000) was obtained from Spectrum Laboratory 





2.2.2.1. Nanoparticle fabrication method 
 Nanoparticles were fabricated by adapting a technique described by Hu et al. (17). 
In this method, nanoparticles were synthesized based on crosslinking polymer chains 
through their carboxyl groups via carbodiimide chemistry. Briefly, aqueous solution of 
polymer (HA or CS) was prepared by mixing polymer in deionized water (2.5 mg/mL, 80 
mL) in a 500 mL round flask. Then, 136 mL acetone was added to the flask and stirred 
for 15 minutes (500 rpm) to make sure all the components in the solution were well 
dissolved. To avoid acetone evaporation, the flask was sealed properly. EDC (80 mg) and 
adipic acid dihydrazide (40 mg) were dissolved in 2 mL of deionized water and added to 
the flask. After mixing the solution for 30 minutes, another 131 mL acetone was added to 
the solution and stirring was continued for another 3 hours (Final HA concentration ~ 
0.57 mg/mL). Then, the reaction was stopped by dialysis of the solution against deionized 
water using dialysis membrane (Regenerated Cellulose (RC), MWCO 50,000). Finally, 






Figure (2-1) (A) Particle fabrication steps. (B) Before dialyzing, light blue color of the 
solution indicates formation of nanoparticles. 
 
 EDC activates carboxyl groups available on HA (or CS) and provides reactive 
intermediates (O-acylisourea derivatives, extremely short-lived) which react with two 
primary amines of adipic acid dihydrazide forming a peptide bond and resulting in the 
neighboring HA (or CS) chains being chemically crosslinked (Figure 2-2). With the first 
addition of acetone, there were no nanoparticles formed in a control experiment. After the 
second addition of acetone, the volume ratio of acetone/water reached to approximately 
269/80 (the ratio range to form HA (or CS) nanoparticles is between 200/80 to 300/80) 
(17). This acetone/water ratio was reported to break the strong hydrogen bonding 
between HA (or CS) chains and HA-water molecules (or CS-water molecules) to release 
carboxyl groups for the crosslinking reaction. After the consumption of carboxyl groups 
by adipic acid dihydrazide, the crosslinked HA (or CS) polymer chains become less 
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soluble (hydrophilic) and were suggested to transform from coils to globules the resulting 




Figure (2-2) Application of carbodiimide chemistry for HA (or CS) nanoparticle 
fabrication. EDC activates carboxyl groups available on HA and provides reactive 
intermediates which react with two primary amines of adipic acid dihydrazide forming 
peptide bonds and resulting in the neighboring HA chains being chemically crosslinked. 
 
2.2.2.2. Particle size and zeta potential characterization 
 Particle size and zeta potential were measured using a ZetaPALS dynamic light 
scattering instrument (Brookhaven, USA) after dispersion of freeze dried nanoparticles in 
deionized water (2 mg/mL). A cryo-transmission electron microscope (FEI field emission 
transmission electron microscope, Tecnai™ G2 at 200 kV) was employed for 
morphological characterization. Cryo-TEM samples were prepared using a Vitrobot™ 
(FEI), a PC-controlled robot for sample preparation. Substratek™ grids with 2-3 nm 
platinum coating on 400 square mesh gold grids were used (Ted Pella Inc., California) for 
sample preparation. First, nanoparticles were dispersed in deionized water at 2 mg/mL 
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concentration. Then, 3 μl of nanoparticle suspension was placed on the grid, blotted to 
reduce film thickness (3 seconds blot time), and vitrified in liquid ethane. Finally, the 
grid was transferred to liquid nitrogen for storage and imaging was performed after 
placing the prepared grid into a cryo sample holder filled with liquid nitrogen. 
 
2.2.2.3. Characterization of bond formation via FTIR 
 To confirm peptide bond formation between HA carboxyl groups and adipic acid 
dihydrazide amine groups, a Spectrum 100 FTIR Spectrometer was used (PerkinElmer, 
Inc., Massachusetts). The FTIR spectra for the starting polymer and fabricated 
nanoparticles were compared. Adipic acid dihydrazide was also used to identify its 
related peaks. 
 
2.2.2.4. Evaluation of crosslinker consumption 
 Analysis of fabricated nanoparticles with trinitrobenzene sulfonic acid (TNBS) 
allows quantification unreacted adipic acid dihydrazide. TNBS is known to react to 
amines, hydrazines, and hydrazides creating a stable trinitrophenyl complex. The 
trinitrophenyl complex of adipic dihydrazide has maximum absorbance at λ=334 nm, 
which can be detected via spectrophotometry (18-20). 
 Briefly, nanoparticles made from 17 kDa HA were dispersed in deionized water at 
5 mg/mL concentration. A 17 kDa HA polymer solution at the same concentration was 
also prepared as a negative control sample. Adipic acid dihydrazide (0.833 mg/mL) was 
also added to separate nanoparticle suspension and polymer solution (5 mg/mL) to make 
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positive controls. To one mL of nanoparticle suspension, negative control, or positive 
controls, 5 µL TNBS solution was added. Then, the samples were incubated at 37 °C for 
one hour to let TNBS react with primary amines of adipic acid dihyadrazide resulting in 
trinitrophenyl complex formation. Finally, 100 µL of each sample was transferred into 
three wells of a 96-well cell culture plate and the absorbance of trinitrophenyl complex of 
adipic acid dihydrazide was measured at λ=334 nm using a microtiter plate reader 
(SpectraMax, M25, Molecular Devices Corp., CA). HA nanoparticle suspension and 
polymer solution (without TNBS) was also used to quantify the absorbance of 
nanoparticles at a similar wavelength. 
 
2.2.2.5. Statistical analysis 
 Statistical analysis was performed using one-way analysis of variance (ANOVA). 
To evaluate the significance of differences, Newman–Keuls was used as a post-hoc test. 
A value of p<0.05 was accepted as significant in all cases. 
 
2.3. Results and Discussion 
2.3.1. Nanoparticle fabrication and the effect of process parameters on 
size and charge of the particles 
 Hyaluronic acid and chondroitin sulfate nanoparticles were successfully 
fabricated. It appears the fabrication of chondroitin sulfate nanoparticles and 
nanoparticles made from different molecular weights of HA has not been reported 
40 
 
previously. This technique could enable fabrication of nanoparticles from other polymers 
if the carobodiimide chemistry is transferable. 
 The effect of polymer concentration (0.28 mg/mL, 0.57 mg/mL, and 2.28 mg/mL) 
on the size and charge of HA (17 kDa) and CS nanoparticles was evaluated (Table 2-1). 
 
Table (2-1) Effect of polymer concentration on size and charge of HA and CS 














0.28 167±15.5 -31±1.1 177±3.1* -50±0.3 
0.57 188±23.9* -32±2.9 282±1.1 -52±1 
2.28 564±27.2** -36±0.7 449±2.1** -49±0.1 
* p<0.005 comparing 0.57 mg/mL to 0.28 mg/mL (HA data) and comparing 0.28 mg/mL 
to 0.57 mg/mL (CS data). 
** p<0.005 comparing 2.28 mg/mL to 0.28 mg/mL (HA data) and comparing 2.28 
mg/mL to 0.57 mg/mL (CS data). 
 
 Increasing polymer concentration increased particle size for both hyaluronic acid 
(HA Mw = 17 kDa) and chondroitin sulfate (CS Mw ~ 30 kDa). The size of HA 
nanoparticles at 2.28 mg/mL polymer concentration was significantly greater than the 
size of the nanoparticles at 0.28 mg/mL and 0.57 mg/mL polymer concentration. CS 
nanoparticles at 0.57 mg/mL polymer concentration were significantly larger than CS 
nanoparticles at 0.28 mg/mL polymer concentration. The data suggested that increasing 
polymer concentration increases particle size. This increase was shown to be independent 
of polymer type and might be due to more intermolecular crosslinking at higher 
concentrations resulting in fabrication of larger particles. CS nanoparticles showed 
greater negative charge values compared to HA nanoparticles. This is likely be due to the 
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presence of functional groups available on CS and ionization of these groups in 
suspension resulting in more negative charge for CS nanoparticles. Finally, these results 
indicated that the charge of the nanoparticles were not significantly different at different 
polymer concentrations. 
 Molecular weight of HA used for nanoparticle fabrication influenced the size of 
the nanoparticles. HA with three different molecular weights (17 kDa, 741 kDa, and 1500 
kDa) was used to evaluate the effect of polymer molecular weight on particle size and 
charge (Table 2-2). 
 
Table (2-2) Effect of HA molecular weight on size and charge of HA nanoparticles. 
Polydispersity values were less than 0.21. Data represent the mean ± SD (n=3).  
HA molecular weight Particle size (nm) Zeta potential (mV) 
17 kDa 188±23.9* -32±2.9 
741 kDa 78±0.7** -21±0.5 
1500 kDa 87±2.5 -26±0.9 
* and ** p<0.005 comparing to 1500 kDa HA. 
 
 Nanoparticles made from 17 kDa HA were larger than nanoparticles made from 
741 kDa HA. Nanoparticles made from 1500 kDa HA were larger than the nanoparticles 
made from 741 kDa HA but they were significantly smaller than the nanoparticles made 
from 17 kDa. The zeta potential of the nanoparticles was not dependent on the HA 
molecular weight and negative charge was observed for all the HA nanoparticles (Table 
2-2). Due to the short length of 17 kDa HA, the chance of intramolecular crosslinking 
during the fabrication of nanoparticles may be less than the chance of intermolecular 
crosslinking. On the other hand, the chance of intramolecular crosslinking of 1500 kDa 
HA may be greater due to its long polymer chain length, more coiled structure, and 
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greater self-association compared to 17 kDa HA (Figure 2-3). This may provide a packed 
structure for nanoparticles made from 1500 kDa HA also resulting in smaller particle size 
compared to nanoparticles made from 17 kDa HA. In addition, more “dangling” chains 
may be available on the nanoparticles made from 17 kDa HA due to the greater chance of 
intermolecular crosslinking compared to nanoparticles made from 1500 kDa (Figure 2-3). 
The presence of dangling chains on the nanoparticles may affect particle-particle and 
particle-polymer interactions which will be discussed in chapters three and four.  
 
 
Figure (2-3) Particle formation and the effect of HA Mw on nanoparticles. 
 
 The effect of process parameters in this nanoparticle fabrication method including 
reaction time and the molar reactive site ratio (-COOH:-NH2) were also evaluated (Table 
2-3). HA with 17 kDa molecular weight was used for this experiment. Three different 
reaction times, 3, 10, and 24 hours were selected for nanoparticle fabrication. Three 
different molar ratio reactive sites (-COOH:-NH2), 1:2 (excess of primary amine groups), 
43 
 
1:1 (equal molar of carboxyl and primary amine groups), and 2:1 (excess of carboxyl 
groups) were theoretically calculated for the experiment (Table 2-3). 
 Increasing reaction time in the formulation with a 1:2 reactive site ratio increased 
particle size. Normally, the carbodiimide reaction is near complete in two hours (21-23). 
Therefore, the increase in particle size may not be the result of further crosslinking over 
time. The presence of larger nanoparticles in this formulation at longer reaction times 
may have been caused by aggregation of nanoparticles. Perhaps this is supported by the 
lack of change of particle charge at different reaction times. Nanoparticles with a 1:2 
reactive site ratio had the largest particle size at all reaction times. That might be due to 
the molar excess of crosslinker resulting in a higher probability of polymer-nanoparticle 
or nanoparticle-nanoparticle reaction (Table 2-3).  
 This study also suggested that the reactive site ratio influenced zeta potential in all 
reaction times. Increasing the relative amount of primary amine groups in the formulation 
decreased particle charge. The greater chance for crosslinking at higher molarities of 
primary amine groups appeared to occupy carboxyl groups and decrease zeta potential 




Table (2-3) Effect of reaction time and molar reactive site ratio (-COOH:-NH2) on size 
and charge of HA nanoparticles. Polydispersity values were less than 0.31. Data represent 
the mean ± SD (n=3). 
Reaction time 
(hours) 
Molar reactive site ratio (-COOH:-NH2) 

















3 298±7.2 -22.33±1.2 188±23.9 -32±2.9 239±10.1 -41±0.02 
10 350±3.8* -27.41±1.1 209±1.3* -33.29±1.1 225±9.3* -38±1.3 
24 501±1.9** -19.3±0.6l 341±0.3 -36.28±1.0 278±7.8 -41±0.2 
* p<0.005 comparing 10 hours data to 3 hours data. 
** p<0.005 comparing 24 hours data to 3 hours data.  
 
2.3.2. Cryo-TEM imaging 
 Cryo-transmission electron microscopy was employed to investigate the 
morphology of HA nanoparticles made from 17 kDa and 1500 kDa HA at 0.57 mg/mL 
polymer concentration, 1:1 molar reactive site ratio, and three hours reaction time. The 
images suggested spherical shape for HA nanoparticles made from both 17 kDa and 1500 





Figure (2-4) Cryo-transmission electron micrographs of hyaluronic acid nanoparticles. 
Left: nanoparticles made from 17 kDa HA, right: nanoparticles made from 1500 kDa HA. 
 
2.3.3. Characterization of bond formation via FTIR 
 To confirm peptide bond formation between HA carboxyl groups and adipic acid 
dihydrazide primary amine groups, Fourier transform infrared spectroscopy (FTIR) was 
employed. The FTIR spectra for the HA nanoparticles (Figure 2-5) showed the 
appearance of a new peak corresponding to the presence of adipic acid dihydrazide (N-N 
bond) (around 1635 cm
-1
). This peak appearance was also observed in FTIR spectra of 
CS nanoparticles (Figure 2-5). The presence of these peaks in the FTIR spectrum after 







Figure (2-5) (A) FTIR spectra of 17 kDa HA polymer (HA-PO) and nanoparticles made 
from 17 kDa HA (HA-NP). (B) FTIR spectra of CS polymer (CS-PO) and CS 





2.3.4. Evaluation of crosslinker consumption 
 A TNBS assay was also used to determine the availability of unreacted primary 
amine groups on the crosslinker after purifying nanoparticles. HA nanoparticles made 
from 17 kDa HA at 0.57 mg/mL polymer concentration, 1:1 molar reactive site ratio, and 
three hours reaction time were employed for this experiment. HA polymer was also used 
as a negative control to compare with the nanoparticles. The TNBS assay revealed that 
the unreacted primary amine groups on crosslinker were not available in the nanoparticle 
suspension after purification due to similar optical density measured at 334 nm for 
nanoparticle sample compared to negative control sample. Therefore, no subsequent side 
reactions would occur in the application of HA nanoparticles in colloidal systems, due to 
elimination of unreacted crosslinker from nanoparticles. 
 
Figure (2-6) Using the TNBS assay as a probe to identify the availability of unreacted 
primary amine groups on crosslinker (PO=Polymer, NP=Nanoparticles, and 



















 In this chapter, a technique adapted from Hu et al. was used to fabricate 
nanoparticles. This method was able to successfully synthesize nanoparticles from both 
hyaluronic acid and chondroitin sulfate using carbodiimide chemistry. Previously, this 
method has not been employed to fabricate nanoparticles from chondroitin sulfate or 
from different molecular weights of hyaluronic acid. It was also observed that 
nanoparticles made from chondroitin sulfate had a more negative charge compared to 
nanoparticles made from 17 kDa HA. The size and charge of nanoparticles was affected 
by polymer concentration, polymer molecular weight, reaction time, and the polymer to 
crosslinker ratio. Increasing polymer concentration increased the particle size; however, 
HA with higher molecular weights led to smaller particles, presumably with less 
“dangling” chains. Moreover, FTIR data also suggested the formation of peptide bonds 
resulting in crosslinking of HA polymer chains via adipic acid dihydrazide. Nanoparticles 
fabricated at 0.57 mg/mL polymer concentration, 1:1 molar reactive site ratio, and three 
hours reaction time were used in chapters three and four to investigate the possibility of 
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Chapter 3: Application of hyaluronic acid nanoparticles for colloidal gel 
fabrication 
3.1. Introduction 
 Colloidal gels are materials made from particles that interact to form three-
dimensional (3-D) networks. Such materials have been suggested as tissue engineering 
scaffolds, drug delivery systems, and biosensors (1, 2). Interparticle interactions 
including electrostatic interactions, van der Waals forces, and steric hindrance enable the 
internal cohesion of colloidal gels. Applying shear force can disrupt these interactions 
allowing the colloidal gels to flow (1-3). To stabilize the structure of colloid-containing 
materials, chemical reactions such as in situ crosslinking have been reported, although the 
application of these reactions are limited due to toxicity (4). Advanced techniques need to 
be developed to stabilize the mechanical properties or to enhance dynamic properties of 
colloidal gels while maintaining compatibility with tissues. 
 The fabrication of moldable colloidal gels has already been reported for tissue 
engineering applications, but few reports utilize nanoparticles made from biomaterials 
commonly used as tissue engineering scaffolds (2, 5, 6). Application of poly(D,L-lactic-
co-glycolic acid) (PLGA) nanoparticles for colloidal gel fabrication was proposed by 
Wang et al. (2, 7). Oppositely charged PLGA nanoparticles formed a cohesive colloidal 
gel through electrostatic interactions between nanoparticles resulting in a moldable 3-D 
network. The colloidal gel could flow by applying shear force as a result of the disruption 
of inter-particle electrostatic interactions. The cohesive property of the colloidal gels was 
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showed to be recoverable after removal of the external shear force. This reversible 
property facilitates injection for drug delivery or tissue engineering (1, 2, 7, 8). 
 Here, a novel colloidal gel based on glycosaminoglycan (GAG) nanoparticles 
(hyaluronic acid or chondroitin sulfate nanoparticles) was explored as a means to form 
stable 3-D networks. As an alternative to inter-particle electrostatic interactions, other 
properties of polymers such as physical entanglement may occur between ‘self-
associating’ polymeric nanoparticles. Several characterization methods were employed to 
evaluate physical, mechanical, and rheological properties of colloidal gels composed of 




3.2. Materials and Methods 
3.2.1. Materials 
 Hyaluronic acid and chondroitin sulfate nanoparticles synthesized as in chapter 
two (section 2.2.2.1) at 0.57 mg/mL  polymer concentration, 1:1 molar reactive site ratio, 
and three hours reaction time were used to make colloidal gel systems. Nanoparticles 
made from 17 kDa HA, 1500 kDa HA, and ~ 30 kDa CS were selected to investigate the 
effect of HA molecular weight and type of GAG on the potency of colloidal gel 
formation. HA (17 kDa and 1500 kDa) manufactured using an extremely efficient 
microbial fermentation process (Lifecore Biomedical, Chaska, Minnesota) and CS (~ 30 
kDa) polymers from bovine cartilage (Sigma-Aldrich, St. Louis, Missouri) were used to 
make controls. 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) 
was purchased from Thermo Scientific (Rockford, Illinois). Adipic acid dihydrazide was 
purchased from Sigma-Aldrich (St. Louis, Missouri). 
 
3.2.2. Methods 
3.2.2.1. Fabrication of colloidal gel 
 Colloidal systems were formed by mixing nanoparticles with deionized water at 
different concentrations. All experiments were performed in triplicate. First, dried 
nanoparticles (HA or CS) were removed from a freezer and equilibrated at room 
temperature. Nanoparticles were weighed and transferred to different microtubes at 
concentrations from 1.4% w/v up to 60% w/v in deionized water. The mixture was 
transferred to cylindrical molds (5 mm diameter and ~ 1.8 mm height) and left for at least 
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five hours. Polymers of HA (17 kDa and 1500 kDa) and CS (~ 30kDa) were used as 
negative controls at similar concentrations to investigate the possible formation of 
physically entangled gels in polymer solutions. Positive controls were also formed by 
adding ECD and adipic acid dihydrazide (with similar molarity used in nanoparticle 
fabrication) to 17 kDa HA polymer solutions at 15%, 30%, and 45% w/v. Positive 
controls were also used to investigate the possibility of gel formation with carbodiimide 
chemistry at similar colloidal gel concentrations. 
 
3.2.2.2. Characterization of colloidal gels via FTIR 
 A Spectrum 100 FTIR Spectrometer (PerkinElmer, Inc., Massachusetts) was 
employed to confirm that no chemical side reaction took place during colloidal gel 
fabrication. The FTIR spectra of the starting polymer, nanoparticles, and colloidal gel 
were compared. 
 
3.2.2.3. Swelling experiment 
 To investigate the swelling behavior and stability of colloidal gels, a swelling 
experiment was carried out as previously described (9-11). All experiments were 
performed in triplicate. Briefly, colloidal gels at 15%, 30%, and, 45% w/v nanoparticle 
concentrations made from 17 kDa HA nanoparticles were placed into an excess of water 
or 0.1 M PBS for at least 6 hours. The equilibrated colloidal gel samples were weighed 
and placed into a desiccator chamber. After 48 hours, the dried colloidal gels were 
weighed again and the swelling ratio of colloidal gels was calculated according to 
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Equation (1) where WS (mg) is the swollen weight and WD (mg) is the dry weight of 
colloidal gels (9-11): 
 
               
(     )
  
                                      ( ) 
 
3.2.2.4. Compression testing and mechanical analysis 
 Compression testing was performed to investigate the mechanical properties of 
samples after fabrication, after swelling in water, and after swelling in 0.1 M PBS. 
Colloidal gels made from 17 kDa HA nanoparticles at 15%, 30%, and 45% w/v were 
used in this experiment. First, samples were placed on a glass slide and the dimensions of 
the cylindrical colloidal gels were determined with calipers using a microscope (Nikon 
TS100F). Since the dimensions of samples changed after swelling in water and 0.1 M 
PBS, samples were initially punched to a diameter of approximately 5 mm. Then, a 
uniaxial compression test using a RSA-III dynamic mechanical analyzer (TA 
Instruments, Delaware) was performed. Sample height was directly measured from the 
instrument. Mineral oil was used to lubricate both compression plates to reduce any 
sample-plate adhesion and prevent sample drying during the test. Compression testing 
was performed at a rate of 0.005 mm/s to obtain a stress-strain curve. The results were 
then analyzed according to the neo-Hookean model for an ideal elastomer in which the 
slope of the stress-strain fraction curve (λ-1/λ
2
, where λ=L/Lo) yields a straight line with a 
slope equal to the shear modulus (9). Young’s modulus, the slope of the stress-strain 
curve, was also estimated based on the linear portion of the stress-strain fraction curve. If 
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the initial region was not a straight line, that region was not considered in calculations. 
Toughness of samples, the absorbed energy, was finally calculated by numerical 
integration of the stress-strain curve (9). All experiments were performed in triplicate. 
 
3.2.2.5. Effect of pH and ionic strength on mechanical properties of HA 
colloidal gel 
 Studies have shown that pH and ionic strength are two important factors that must 
be considered for injected formulation (12-14). Moreover, the influence of these factors 
on HA structure and hydrodynamic radius was briefly discussed in chapter one (15). To 
investigate the effect of pH and ionic strength on the formation of HA colloidal gels and 
their mechanical properties, phosphate buffer (phosphate buffer concentration=10 mM) 
was made at three different pH values (pH=6, 7.4, and 8). This range covers the reported 
local pH tolerance for subcutanous injection (12-14). Sodium phosphate was chosen as 
buffer at pH=6 since other buffers such as citrate are known to be painful for injection 
(12). Usually, an isotonic solution containing 150 mM salt was reported for injection (12, 
14). In order to explore an ionic strength range similar to isotonic solution, three different 
ionic strengths (100 mM, 150mM, and 200 mM) were selected for the buffer 
formulations. The buffers were prepared by mixing sodium phosphate salt and sodium 




3.2.2.6. Viscoelasticity of HA colloidal gel after fabrication 
 In order to investigate the viscoelasticity of HA colloidal gels, dynamic 
oscillatory rheological measurements were performed using an AR 2000 rheometer (TA 
Instruments, Delaware) equipped with a 2°, 20 mm diameter cone-plate geometry at a 
controlled temperature of 25 °C. HA colloidal gel samples were prepared by mixing 
nanoparticles (made from 17 kDa HA) at different concentrations (5%, 15%, 30%, 45% 
w/v) in deionized water. 17 kDa HA polymer was also dissolved in deionized water at 
45% w/v concentration as negative control. First, strain sweep experiments were 
performed to determine the linear viscoelastic regime, where the rheological properties 
are not strain dependent. Then, the viscoelastic properties of colloidal gels were evaluated 
using a frequency sweep from 0.1 to 10 Hz at 1% strain, which was in the linear 
viscoelastic region. This range includes the physiological frequencies of the knee, 
ranging from 0.5 Hz (walk) to 3 Hz (running) (16-19). All experiments were performed 
in triplicate. 
 In the oscillatory experiment, a sinusoidal shear strain was applied to the samples 
accordingly to:  
 
       (  )                                          ( ) 
  
where    is the shear strain amplitude,   is the oscillation frequency and   is the time. 
The mechanical response, expressed as the shear stress ( ) of viscoelastic materials, 
ranges from an ideal pure elastic solid (follows Hooke’s law) and an ideal pure viscous 
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fluid (follows Newton’s law) (16). If viscoelastic, the mechanical response is out of phase 
by   from Eq. (5) with respect to the imposed deformation as stated by: 
 
    ( )     (  )   
  ( )     (  )                    ( ) 
 
where   ( ) is the shear elastic modulus giving information about elasticity or the 
energy stored in the material during deformation and    ( ) is the shear viscous modulus 
which describes the viscous characteristic or the energy scattered as heat (16). 
 The combined viscous and elastic behavior is defined by the absolute value of 
complex shear modulus    (16): 
 
  ( )  √                                                   ( ) 
 
 The ratio between the viscous modulus and the elastic modulus is defined by the 
loss tangent (tan delta): 
 
     
   
  
                                                  ( ) 
 
 The loss tangent is the ratio of the energy lost to the energy stored in the cyclic 
deformation (16-18).  
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3.2.2.7. Viscosity of HA colloidal gel 
 The viscosity of the different formulations was determined using an AR 2000 
rheometer (TA Instruments, Delaware) equipped with a 2°, 20 mm diameter cone-plate at 
25 °C. HA nanoparticles (made from 17 kDa HA) were mixed with deionized water at 
different concentrations (5%, 15%, 30%, 45% w/v). Shear stress and viscosity of the 
samples were measured over a shear rate sweep of 0.01-100 s
-1
. 17 kDa HA polymer was 
also dissolved in deionized water at 45% w/v concentration as a negative control. All 
experiments were performed in triplicate. 
 
3.2.2.8. HA colloidal gel recovery 
3.2.2.8.1. Mechanical dynamics and recovery 
 To characterize recovery and the dynamic behavior of HA colloidal gels, 
compression testing was performed as described in section 3.2.2.4. Two sets of samples 
(after fabrication and swollen in 0.1 M PBS) were prepared for this experiment. After 
fabrication of colloidal gels at different nanoparticle concentrations (15%, 30%, and 45% 
w/v), one set of samples was swollen in 0.1 M PBS solution for at least 24 hours. Each 
sample was punched to a diameter of approximately 5 mm. After loading each sample, 
five preconditioning compression cycles at 6% strain were applied to initiate the recovery 
experiment. Then, a compression at 30% strain (0.005 mm/s) was applied. After 
squeezing the sample, compression force was removed and the sample was allowed to 
relax for five minutes. Meanwhile, the sample was hydrated with deionized water to 
prevent dryness. Finally, another compression at 30% strain (0.001 mm/s) was applied. 
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The mechanical recovery and dynamic property of samples were identified by comparing 
the recovered height of the samples after the second compression to the height of the 
samples before the first compression. Normal stress-gap curves were generated and used 
to identify the recovery. All experiments were performed in triplicate. 
 
3.2.2.8.2. Rheological recovery 
 To evaluate the rheological recovery of colloidal gels, the viscosity was measured 
as in section 3.2.2.7. Samples at 15% w/v nanoparticle concentration in deionized water 
were prepared for this experiment. Then, the colloidal gel was loaded under the 
rheometer and three cycles of shear rate sweeps (0.01-100 s
-1
) with a one minute delay 
between each cycle were applied to the samples. The changes in shear stress and 
viscosity over shear rate sweep after each run was evaluated. All experiments were 
performed in triplicate. 
 
3.2.2.8.3. Physical recovery 
 To evaluate the physical recovery of the colloidal gel, samples at 30% w/v 
nanoparticle concentration in deionized water were prepared. The samples were swollen 
in water for at least 24 hours. Then, the swollen samples were completely crushed and 
dried in a desiccator for at least 48 hours. Finally, dried samples were weighed and again 
the colloidal gel samples at 30% w/v were remade. The physical recovery of the samples 
was evaluated by visual observation. All experiments were performed in triplicate.  
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3.2.2.9. Statistical analysis 
 Statistical analysis was performed by one-way analysis of variance (ANOVA). To 
evaluate the significance of differences, Newman–Keuls was used as a post-hoc test. A 
value of p<0.05 was accepted as significant in all cases. 
 
3.3. Results 
3.3.1. Fabrication of colloidal gel 
 Colloidal gels were formed by mixing nanoparticles with deionized water at 
different concentrations. Samples were made from 17 kDa and 1500 kDa HA (Figure 3-
1). These nanoparticles were assumed to have different structural properties. 17 kDa HA 
nanoparticles were suspected to have a more ‘hairy’ structure with dangling chains 
compared to 1500 kDa HA nanoparticles. Colloidal gels with a stable 3-D structure 
formed at 15%, 30%, and 45% w/v when nanoparticles made from 17 kDa HA were 
used. Colloidal gels could also hold their structure upon swelling in deionized water. At 
5% w/v nanoparticle concentration, the mixture could not form a stable 3-D structure; 
however, a viscous suspension of HA nanoparticles was obtained (Figure 3-1, B). That 
might be because of the physical entanglement between dangling chains of nanoparticles. 
On the other hand, 17 kDa HA polymer solutions at 5%, 15%, 30%, and 45% were liquid 
and a 3-D network was not evident (Figure 3-1, A). Even positive controls using EDC 
and adipic acid dihydrazide with hyaluronic acid resulted in no gel formation at similar 
concentrations. Positive controls were made by activating carboxyl groups of 17 kDa HA 
via EDC and trying to crosslink them via adipic acid dihydrazide in deionized water (but 
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without acetone in this case) at similar concentrations to colloidal gel formulations 
(Figure 3-1, C). 
 Mixing nanoparticles fabricated from 1500 kDa HA at 1.4%, 5%, 10%, 15%, 
30%, and 45% w/v concentrations did not form any stable colloidal gel network (Figure 
3-1, E). At lower concentrations (1.4%, 5%, 10%, and 15% w/v), formation of a low 
viscosity nanoparticle suspension was observed; however, at 30% and 45% w/v 
nanoparticle concentrations, paste-like materials were obtained (Figure 3-1, E and F). 
Mixing 1500 kDa HA polymer with deionized water at 1.4% w/v resulted in formation of 
a viscous polymer solution however at 5%, 10%, and 15% w/v polymer concentrations, 
3-D gels formed (Figure 3-1, D). These gels, however, could be dissolved while swelling 
in deionized water.  
 Results showed that at 15%, 30%, and 45% w/v nanoparticle concentrations (17 
kDa HA nanoparticles), colloidal gels with stable 3-D structure were formed. In contrast, 
paste-like materials were formed in the samples made from 1500 kDa HA nanoparticles 
at similar concentrations. Formation of stable colloidal gels in the samples made from 17 
kDa HA nanoparticles may be due to physical entanglement of the dangling chains 
available on the surface of 17 kDa HA nanoparticles. On the other hand, the absence of 
these dangling chains on the nanoparticles made from 1500 kDa HA negated physical 





Figure (3-1) (A) 17 kDa HA polymer solutions (HA-PO) at different concentrations (5%, 
15%, 30%, and 45% w/v). (B) Colloidal gels (HA-NP) formed at different HA (17 kDa) 
nanoparticles concentrations (15%, 30%, and 45% w/v). (C) Carbodiimide chemistry also 
did not form stable gel at different HA (17 kDa) concentrations. (D) 1500 kDa polymer 
solutions (HA-PO) at different concentrations (1.4%, 5%, 10, 15% w/v). (E) Nanoparticle 
suspensions (HA-NP) formed at different HA (1500 kDa) nanoparticles concentrations 
(1.4%, 5%, 10, 15% w/v). (F) Formation of paste-like materials was observed at 30% and 






Figure (3-2) (Top) Physical entanglement due to the presence of dangling chains on the 
surface of 17 kDa HA nanoparticles may facilitate formation of stable colloidal gel 
networks. (Bottom) Due to the absence of dangling chains on 1500 kDa HA 





 Chondroitin sulfate (CS) (~ 30 kDa) nanoparticles were also tested; however, a 
stable 3-D structure network did not form even at high concentration of CS nanoparticles 
(60% w/v). Mixing CS nanoparticles with deionized water only formed colloidal 
suspensions. This might be due to the absence of physical properties such as 
entanglement and self-association of CS polymer chains compared to hyaluronic acid 
(Figure 3-3).  
 
 
Figure (3-3) Colloidal gel networks did not form when using chondroitin sulfate 
nanoparticles even at 60% w/v concentration. 
 
3.3.2. Characterization of colloidal gels via FTIR 
 FTIR spectra of HA polymer, HA nanoparticles, and HA colloidal gel at 30% w/v 
nanoparticle concentration (17 kDa HA) showed that no chemical side reaction occurred 





Figure (3-4) FTIR spectra of HA polymer (HA-PO), HA nanoparticles (HA-NP), and 
HA colloidal gel (HA-Gel) at 30% w/v concentration. The results indicated that chemical 
side reactions did not occur during colloidal gel formation (17 kDa HA). 
 
3.3.3. Swelling experiment 
 The swelling ratio of HA colloidal gels at different nanoparticle (17 kDa HA) 
concentrations (15%, 30%, and 45% w/v) were measured at 6 and 24 hours (Figure 3-5 
and Figure 3-6). The swelling ratio of samples swollen in deionized water was greater 
than the swelling ratio of samples swollen in 0.1 M PBS. The presence of salt in 0.1 M 
PBS solution may keep the HA structure more coiled with a lower hydrodynamic radius 
resulting in less swelling of nanoparticles (15). Increasing nanoparticle concentration 
decreased the swelling ratio for the samples swollen in both water and 0.1 M PBS. More 
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physical entanglement between nanoparticles was expected at higher concentrations. 
Finally, HA colloidal gels swollen in water and 0.1 M PBS could hold their stable 3-D 




Figure (3-5) Swelling experiment on colloidal gels after 6 hours incubation. Samples 
with lower nanoparticle concentrations tended to swell more in both water and 0.1 M 
PBS. Samples tended to swell more in water at all concentrations. Data represent the 
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Figure (3-6) Swelling experiment on colloidal gels after 24 hours incubation. Samples 
with lower nanoparticle concentrations tended to swell more in both water and 0.1 M 
PBS. Samples tended to swell more in water at all concentrations. Swelling ratios were 
higher after 24 hours incubation than swelling ratios after 6 hours incubation. Data 
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3.3.4. Compression testing and mechanical analysis 
 Uniaxial compression testing was performed on colloidal gels at 15%, 30%, and 
45% w/v nanoparticle concentrations (17 kDa HA) after fabrication, and after swelling in 
deionized water or 0.1 M PBS. Stress-strain curves collected for colloidal gels after 
fabrication suggested that the colloidal gels behave as soft materials without a failure 
point (Figures 3-8). Samples did not even break during compression testing up to 80% 
strain. After removing the force, samples could recover their initial shape over time (~ 5 
minutes) before and after compression testing up to 80% strain (Figure 3-9). 
 
 
Figure (3-8) Compression testing up to 80% stain on colloidal gels after fabrication. A 

































Figure (3-9) Colloidal gels before and after compression testing (80% strain, 0.005 
mm/s). After removing the force, samples could recover their initial shape over time (~ 5 
minutes). 
 
 In addition, stress-strain curves were collected for the samples swollen for 24 
hours in deionized water (Figure 3-10). Samples at different nanoparticle concentrations 
broke with different stress and strain values (Table 3-1). Increasing nanoparticle 
concentration increased the slope of the curves indicating stiffer materials (higher E) 
(Figure 3-10 and Figure 3-12). Similar behavior was also observed for the samples 
swollen in 0.1 M PBS. Swollen samples failed at different stress strain values depending 
on the nanoparticle concentration (Table 3-1). Increasing nanoparticle concentration 





Figure (3-10) Uniaxial compression testing of colloidal gels after swelling in deionized 
water. 
 



























































 Young’s modulus (E) is defined as the initial slope of stress-strain curves 
indicating the stiffness of material. Young’s modulus of colloidal gels was determined at 
different conditions (Figure 3-12). Increasing nanoparticle concentration increased 
Young’s modulus. This increase was greater for the samples swollen in deionized water. 
Moreover, samples swollen in deionized water had the highest Young’s modulus. 
Perhaps due to the decrease in chain entanglement in 0.1 M PBS due to ionic strength 
(15). 
 In addition, the Young’s modulus of colloidal gel samples at 15%, 30% and 45% 
w/v were statistically different (Figure 3-12). Increasing nanoparticle concentration 
significantly increased the Young’s modulus of the samples swollen in deionized water 
and 0.1 M PBS. Based on these results, Young’s modulus is a concentration dependent 






Figure (3-12) Calculated Young’s modulus for colloidal gels at different conditions 
(after fabrication, swollen in deionized water, or swollen in 0.1 M PBS). Increasing 
nanoparticle concentration increased Young’s modulus. Samples swollen in water had the 
highest modulus. Data represent the mean ± SD (n=3). * and ** p<0.05 as compared to 
HA-NP-15% w/v. 
 
 Based on the neo-Hookean model, the initial slope of the stress versus stain 
function curve (where the curve is linear) is identified as the shear modulus (G), the 
rigidity of material (9). The shear modulus of colloidal gels was determined at different 
conditions (Figure 3-13). Increasing nanoparticle concentration increased the shear 
modulus for all conditions; however, this increase was more pronounced in the samples 
after fabrication. Similar to Young’s modulus, nanoparticle concentration and salt content 



























Figure (3-13) Calculated shear modulus for colloidal gels at different conditions (after 
fabrication, swollen in deionized water, or swollen in 0.1 M PBS). Increasing 
nanoparticle concentration increased shear modulus. Data represent the mean ± SD (n=3). 
* and ** p<0.05 as compared to HA-NP-15% w/v. 
 
 For incompressible materials (ideal elastomers) such as hydrogels, E was reported 
to be approximately equal to 3G (   (   ) ,  ~1/2) (9). E/G values identify the 
relationship between the stiffness and rigidity of the material and E/G was calculated for 
colloidal gels at different conditions (Figure 3-14). Obviously, colloidal gels were 
elastomeric materials but did not behave as an ideal neo-Hookean elastomer. The data 
suggested that Young’s modulus is less than 3G. Increasing nanoparticle concentration 
from 15% to 30% w/v increased E/G for the samples swollen in deionized water. In 





























swollen in 0.1 M PBS at similar concentrations. The influence of nanoparticle 
concentration on E/G did not follow a similar pattern for all sample conditions. 
 
Figure (3-14) Calculated E/G for colloidal gel samples at different nanoparticle 
concentrations (after fabrication, swollen in deionized water, or swollen in 0.1 M PBS). 
Data represent the mean ± SD (n=3). * and ** p<0.05 as compared to HA-NP-15% w/v. 
 
 Compressive failure properties were determined for samples swollen in deionized 
water or 0.1 M PBS (Table 3-1). Failure strain of samples swollen in water was 
significantly lower than the failure strain of samples swollen in 0.1 M PBS at all 
nanoparticle concentrations. Increasing nanoparticle concentration, increased stress 
failure and toughness for samples swollen in deionized water or in 0.1 M PBS. The 
toughness of samples swollen in deionized water was statistically different from the 

























concluded that the increase of failure stress and toughness might be due to greater 
physical entanglement between nanoparticles at higher nanoparticle concentrations. 
 
Table (3-1) Compressive failure properties of colloidal gels swollen in deionized water 
or 0.1 M PBS. Data represent the mean ± SD (n=3).  
Gel formulation Compressive failure properties 
 Swollen in water Swollen in 0.1M PBS 














HA-NP 15% (w/v) 30±2.1 3±0.16 0.3±0.032 53±3.4 1±0.7 0.5±0.082 
HA-NP 30% (w/v) 26±3.4 5±1.6* 0.6±0.183 60±1.5 10±0.24 2.7±0.365* 
HA-NP 45% (w/v) 21±1.4** 6±2.5** 0.6±0.234 48±2.6 16±4.6 3.3±0.667** 
* and ** p<0.05 comparing to HA-NP 15% w/v. 
 
3.3.5. Effect of pH and ionic strength on mechanical properties of HA 
colloidal gel 
 The stress-strain curves were determined for samples at 15% w/v nanoparticle 
concentration and different pH values (17 kDa HA) (Figure 3-15). Increasing pH 
influenced the behavior of material as was observed from the calculated Young’s 
modulus and shear modulus which showed that the material become softer at higher pH 
values. Increasing pH at 150 mM salt concentration decreased both Young’s modulus and 
shear modulus; however, this decrease was not significant for all the samples. Increasing 
pH can reduce the hydrodynamic radius of HA (15). Therefore, the physical 
entanglement between nanoparticles may decrease at higher pH values resulting in 
formation of softer materials. The highest values for Young’s modulus and shear 





Figure (3-15) Compression testing up to 70% stain on colloidal gels after fabrication in 
phosphate buffer solutions at different pH values (6.0, 7.4, and 8) and constant ionic 
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Figure (3-16) Calculated Young’s modulus, shear modulus, and E/G for colloidal gels at 
different pH values and constant ionic strength (150 mM). Increasing pH decreased 
Young’s modulus and shear modulus. Data represent the mean ± SD (n=3). 
 
 Changing the salt concentration at a constant pH of 7.4 also affected the 
mechanical properties of colloidal gels at 15% w/v nanoparticle concentration (17 kDa 
HA). Increasing salt concentration made colloidal gels softer (Figure 3-17). Young’s 
modulus and shear modulus appeared greater at lower salt concentrations; however, the 
results were not statistically significant (Figure 3-18). The presence of salt in the 
formulations can influence the structure and reduce HA hydrodynamic radius (15). 
Therefore, this effect may also decrease physical entanglement between nanoparticles 





















Figure (3-17) Compression testing up to 70% stain on colloidal gels in phosphate buffer 
solutions at different ionic strength values (100, 150, and 200 mM) and a pH of 7.4. A 
failure point was not observed for the samples. 
 
Figure (3-18) Calculated Young’s modulus, shear modulus, and E/G for colloidal gels at 
different ionic strength values and constant pH of 7.4. Data represent the mean ± SD 
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3.3.6. Viscoelasticity of HA colloidal gel after fabrication 
 Viscoelastic properties were evaluated for HA colloidal gels using different 
nanoparticle concentrations. Nanoparticles made from 17 kDa HA were used to make 
colloidal gels at 5%, 15%, 30%, and 45% w/v. 17 kDa HA polymer at 45% w/v in 
deionized water was also used as a control. The changing elastic modulus (G’) of 
colloidal gels was determined over a frequency range of 0.1-10 Hz (Figure 3-19). 
Increasing nanoparticle concentration increased the elastic modulus of colloidal gels. 
Samples at 5% w/v nanoparticle concentration had a similar elastic modulus compared to 
the 45% polymer solution. The elastic modulus of other colloidal samples was greater 





Figure (3-19) Viscoelasticity of colloidal gels: elastic modulus over frequency range. 
Increasing nanoparticle concentration increased elastic modulus. Data represent the mean 
± SD (n=3). 
 
 Increasing nanoparticle concentration also increased the viscous modulus (G”) of 
colloidal gels (Figure 3-20). Samples at 5% w/v nanoparticle concentration showed a 
similar viscous modulus compared to the 45% polymer solution. The viscous modulus of 

























Figure (3-20) Viscoelasticity of colloidal gels: viscous modulus over frequency range. 
Increasing nanoparticle concentration increased viscous modulus. Data represent the 
mean ± SD (n=3). 
 
 The calculated complex modulus (G*) showed behavior similar to the elastic and 
loss moduli over frequency range (Figure 3-21). Samples at 5% w/v nanoparticle 

























Figure (3-21) Viscoelasticity of colloidal gels: complex modulus over frequency range. 
Increasing nanoparticle concentration increased complex modulus. Data represent the 
mean ± SD (n=3). 
 
 Excluding data for the sample at 5% w/v concentration, tan delta was also 
increased by increasing the concentration of nanoparticles (Figure 3-22). Since a stable 3-
D structure was not formed at 5% w/v, the calculated tan delta for this sample showed a 


























Figure (3-22) Viscoelasticity of colloidal gels: tan delta over frequency range. Data 
represent the mean ± SD (n=3). 
 
3.3.7. Viscosity of HA colloidal gel 
 The viscosity of colloidal gels was measured at different nanoparticle 
concentrations in deionized water (Figure 3-23). Changes in viscosity over shear rate 
sweep are also presented (Figure 3-24). The 17 kDa HA polymer solution at 45% w/v 
concentration was used as a control to compare the behavior of colloidal gels with 
polymer solution. 
 Results showed that samples at 5% w/v behaved similar to the control since a 
colloidal gel network did not form at that concentration. By increasing nanoparticle 
concentration up to 15% w/v and higher, the behavior of the samples changed. A yield 























addition to that, increasing nanoparticle concentration increased shear stress and viscosity 
of the samples. At lower shear rates, the viscosity of samples increased to a maximum 
(yield point) and then dropped by increasing shear rate. This yield point correlated to the 
yield stress point on shear stress-shear rate curves. Increases in the viscosity and shear 
stress up to the yield point might be due to the interlocking of dangling chains available 
on the surface of nanoparticles (Figure 3-24). After the yield point, nanoparticles may 
thus lower the shear stress and viscosity at higher shear rates. The colloidal gels shear 
thinned after the yield point, which indicated a “pseudo-plastic” material (Figure 3-24). 
 
 
Figure (3-23) Rheological evaluation of HA-NP (17 kDa) for nanoparticles in deionized 

































Figure (3-24) Rheological evaluation of HA-NP (17 kDa) for nanoparticles in deionized 
water. Increasing nanoparticle concentration increased viscosity. 
 
3.3.8. HA colloidal gel recovery 
3.3.8.1. Mechanical dynamics and recovery 
 Recovery of colloidal gels at 15%, 30%, and 45% w/v nanoparticle 
concentrations (17 kDa HA) tested after fabrication and after swelling in 0.1 M PBS. 
Representative stress-gap curves were collected for all the tested formulations (Figure 3-
25). Results suggested that after the first cycle of compression/decompression, the height 
of the samples recovered back to the initial height. This might be due to the structural 
properties of the colloidal gel samples including chemical crosslinking in the 
nanoparticles, physical entanglement between nanoparticles, and the nature of HA itself. 





























Moreover, similar recovery behavior was observed for both conditions (after fabrication 
and after swelling samples in 0.1 M PBS). Due to the failure of samples swollen in 
deionized water at strains less than 30%, mechanical recovery experiments were not 






Figure (3-25) The recovery of colloidal gels (15%, 30%, and 45% w/v) after fabrication 
(A, B , and C) and swollen in 0.1 M PBS (D, E, and F) was determined by applying two 
compression\decompression cycles with 5 minutes delay time between cycles. Data 
represent the mean ± SD (n=3): C1: 30% strain, 0.005 mm/s. C2: 30% strain, 0.001 
mm/s. Five preconditioning cycles were also applied before the recovery experiment at  




























































































































































































3.3.8.2. Rheological recovery 
 The rheological recovery of samples at 15% w/v nanoparticle concentration was 
also evaluated after colloidal gel fabrication (Figure 3-26 and Figure 3-27). The viscosity 
of the colloidal gels was recoverable after applying shear stress to the samples. These 
results suggested that surface chains could re-associate after disruption by shear force. 
After applying shear force, samples still had similar rheological behavior compared to the 
initial material which suggests recovery of the colloidal gel network after applying shear. 
Studies have shown a reduction in the viscosity of HA solutions after applying shear 
stress and HA has been found to degrade under shear (15, 20-22). The slight drop in 
viscosity after the first sweep might be due to the degradation of HA or an insufficient 






Figure (3-26) Colloidal gel recovery based on rheology. After applying shear stress to 
the sample (15% w/v nanoparticle concentration), shear recovery was observed after a 
































Figure (3-27) Colloidal gel recovery based on rheology. After applying shear stress to 
the sample (15% w/v nanoparticle concentration), shear recovery was observed after a 
one minute delay between cycles. 
 
3.3.8.3. Physical recovery 
 Colloidal gels at 30% w/v nanoparticle concentration (17 kDa HA) formed a 
network after fabrication and after swelling in deionized water. The steps for performing 
this recovery experiment are shown in Figure 3-28. First, nanoparticles made from 17 
kDa HA were used to make the colloidal gel at 30% w/v concentration. The colloidal gel 
was then swollen and equilibrated in deionized water for at least 24 hours. After swelling 
the sample, the colloidal gel was completely crushed. Then, the sample was transferred to 
a desiccator chamber and left to dry for at least 48 hours. Finally, the dried sample was 
again used to form a colloidal gel network at 30% w/v nanoparticle concentration in 






























suggested that dangling chains available on nanoparticles could entangle with each other 
even after colloidal gel destruction. 
 
 
Figure (3-28) Physical recovery tests suggested that the colloidal gel networks could be 
reformed from destroyed colloidal gels. 
 
3.4. Discussion 
 Colloidal gel networks were formed by addition of HA nanoparticles in deionized 
water. The type of polymer, molecular weight of polymer, and nanoparticle concentration 
significantly influenced nanoparticle-nanoparticle interactions and colloidal gel 
formation. Stable 3-D colloidal gel networks formed at 15%, 30%, and 45% 
concentrations when using nanoparticles fabricated with 17 kDa HA. At these 
concentrations, physical entanglement between 17 kDa HA nanoparticles with ‘hairy’ 
structure might be the reason for colloidal gel formation. After mixing nanoparticles with 
deionized water, dangling chains on the nanoparticles might entangle and interlock 
resulting in formation of stable colloidal gels. Colloidal gels did not form at 5% w/v 
when 17 kDa HA nanoparticles were used. This was likely due to insufficient 
nanoparticle concentration to achieve physical entanglement. On the other hand, HA 
nanoparticles made from 1500 kDa HA could not form colloidal gel networks even at 
high concentration probably due to the limited availability of dangling chains on these 
nanoparticles. Also, CS nanoparticles could not form colloidal gel networks probably due 
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to the nature of CS and the absence of physical entanglement or ‘self-association’ in this 
highly charged GAG. 
 Swelling experiments suggested that colloidal gel networks were stable upon 
dilution in an excess of deionized water and in 0.1 M PBS. The results also indicated that 
the swelling ratio was dependent on nanoparticle concentration and the nature of the 
swelling solution. Increasing nanoparticle concentration may increase physical 
entanglement between nanoparticles reducing the swelling ratio. Moreover, the presence 
of salt in swelling solution is known to reduce hydrodynamic radius of HA and physical 
entanglement. As a result, the swelling ratio of the samples in 0.1 M PBS was lower than 
the swelling ratio of the samples in deionized water. A comparison of HA colloidal gels 
and classic HA hydrogels including HA crosslinked via divinyl sulfone (DVS), 
photocrosslinked methacrylated HA, dual-crosslinked HA (photo crosslinked and 
chemically crosslinked), and HA via crosslinked disulfide bond formation, showed that 
the swelling ratio of the colloidal gels was in the range of a maximum swelling ratio of 
classic gels (i.e. a low degree of crosslinking) (10, 23-26).   
 In addition, compression testing also suggested that the mechanical properties of 
colloidal gels (Young’s and shear moduli) were influenced by nanoparticle concentration 
and sample condition. Increasing nanoparticle concentration made colloidal gels stiffer. 
Moreover, samples swollen in deionized water had greater Young’s modulus compared to 
the samples after fabrication or to samples swollen in 0.1 M PBS. These behaviors may 
also hinge on the physical entanglement between nanoparticles which was influenced by 
nanoparticle concentration and sample condition. In addition, compression testing 
indicated that colloidal gels behaved as a softer material compared to classic HA 
96 
 
hydrogels. Maximum Young’s and shear moduli of the colloidal gels reached 
approximately 20 kPa; however, normal Young’s and shear moduli values for HA 
crosslinked with DVS were in the range of several thousand kPa (23, 26). Comparing the 
shear modulus of colloidal gels with photocrosslinked methacrylated HA (20<G<60 kPa) 
also showed that the colloidal gels had softer mechanical properties (24). Only the initial 
portion of strain-stress curves, where the stress-strain function curves were linear, was 
used to calculate the mechanical properties of colloidal gels, where was though the 
colloidal gels have ideal elastic behavior.  The compression testing data (E/G values) 
showed that the colloidal gels were elastomeric materials but did not behave as an ideal 
neo-Hookean elastomer.  
 In other studies, nanoparticle concentration had an important effect on rheological 
behavior of colloidal gels. Increasing nanoparticle concentration increased elastic 
modulus, viscous modulus, complex modulus, and tan delta of the samples after 
fabrication. Moreover, viscosity of the samples upon mixing nanoparticles with deionized 
water increased by increasing nanoparticle concentration. The shear stress and viscosity 
of the colloidal gels increased up to a yield point by increasing the shear rate. After the 
yield point, viscosity of the samples decreased by increasing the shear rate indicative of 
shear thinning behavior for the colloidal gels. Viscoelasticity measurements also 
indicated that colloidal gels had a similar elastic modulus, viscous modulus, and complex 
modulus compared to a classic hydrogel. Previous viscoelasticity evaluation of HA 
crosslinked via DVS showed that the elastic and loss moduli were in the range of several 
hundred to several thousand Pa and the colloidal gels had similar viscoelasticity (23). 
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 Finally, recovery experiments revealed the dynamic properties of colloidal gels. 
Mechanical experiments suggested that the height of the samples was recoverable to the 
original height after compressing/decompressing samples independent of nanoparticle 
concentration. Rheological experiments also showed that the viscosity of the colloidal 
gels was recoverable after applying shear stress to the samples. These results support the 
notion that the interrupted physical entanglement between surface chains on nanoparticles 
could re-associate after removing shear force. A physical recovery experiment showed 




 In conclusion, colloidal gel networks were formed by mixing HA nanoparticles in 
deionized water. The type of polymer, molecular weight of polymer, and nanoparticle 
concentration significantly influenced nanoparticle-nanoparticle interactions and colloidal 
gel formation. Stable 3-D colloidal gel networks formed at 15%, 30%, and 45% 
concentrations when using nanoparticles fabricated with 17 kDa HA due to physical 
entanglement between nanoparticles. CS nanoparticles and nanoparticles made from 1500 
kDa HA could not form colloidal gel networks probably due to limited availability of 
surface chains to mediate nanoparticle-nanoparticle interactions. Mechanical and 
rheological experiments showed that Young’s modulus, shear modulus, viscosity, and 
viscoelasticity of colloidal gels were influenced by nanoparticle concentration which 
might increase the chance of physical entanglement between ‘hairy’ nanoparticles and 
media type. These data also showed that the colloidal gels did not behave as an ideal neo-
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Hookean elastomer. Finally, recovery experiments confirmed that colloidal gels had 
dynamic properties. Formation of stable 3-D colloidal gels using HA nanoparticles 
without any potentially toxic chemical reactions suggests a new approach for scaffold 
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Chapter 4: Application of hyaluronic acid nanoparticles in colloidal 
suspensions as a potential osteoarthritis treatment 
4.1. Introduction 
 Currently, the quality of life for ~33 million Americans is affected by 
osteoarthritis (OA) with about 70% of these individuals aged 65 and over (1-3). OA is a 
disease in which the degradation of joints results in pain and loss of joint function. Intra-
articular treatments, such as hyaluronic acid (HA) injections into the synovial joint, are 
normally recommended to reduce the pain and increase joint function. HA is a major 
component of synovial fluid lubricating the joint and preventing joint erosion (4). HA 






 are available on the 
market (5-7). While these products have shown positive effects, reducing pain and 
increasing joint function, poor injectability or insufficient therapeutic effect remain a 
need (5-7). 
 To enhance injectivity, multiple studies have been conducted and several low 
viscosity products are available on the market. Using HA with lower molecular weights 
has been the primary means to reduce viscosity of vicosupplements; however, low 
molecular weight HA does not provide a sufficient therapeutic effect. Hyalgan
®
 is one of 
these low molecular weight, uncrosslinked HA viscosupplements. More injections of 
Hyalgan
®
 are required per treatment course to achieve a reasonable therapeutic effect 
(Table 1-5). On the other hand, treatment with crosslinked HA viscosupplements such as 
Synvisc
®




 Here, HA nanoparticles were explored as a means to reduce the viscosity of 
viscosupplements using high molecular weight HA. Orthovisc
® 
is made from 
uncrosslinked 1500 kDa HA and has the highest concentration of HA among the 
uncrosslinked viscosupplements (Table 1-5). In this study, HA nanoparticles were used to 
reduce the viscosity of HA solutions with similar molecular weight and concentration to 
Orthovisc
®
. Two experiments were designed to investigate the effect of nanoparticles on 
the rheological behavior (viscosity and viscoelasticity) of simulated Orthovisc
®
. A 
solution of 1500 kDa at 1.4% w/v was prepared as a model viscosupplement for 
osteoarthritis treatment. The effect of including nanoparticles at different ratios and 




4.2. Materials and Methods 
4.2.1. Materials 
 Nanoparticles fabricated in chapter two (section 2.2.2.1) at 1X polymer 
concentration, 1:1 molar reactive site ratio, and three hours reaction time made from 17 
kDa and 1500 kDa HA were used in this chapter for the experiments. 
 
4.2.2. Methods 




4.2.2.2.1. Mixing HA nanoparticles with HA polymer to reach 
hyaluronic acid concentration simulated Orthovisc
®
 formulation 
 To evaluate the effect of HA nanoparticles in a simulated Orthovisc
® 
formulation, 
an overall HA concentration was set at 1.4 w/v which is the same concentration of 
hyaluronic acid (1500 kDa) in Orthovisc
®
. Two sets of samples were prepared by mixing 
nanoparticles made from 17kDa HA or nanoparticles made from 1500 kDa HA with 1500 
kDa HA polymer at different nanoparticle: polymer ratios to reach the final HA 
concentration of 1.4% w/v in deionized water. Polymer to nanoparticle ratios were 
selected as: 100:0, 75:25, 50:50, 25:75, and 0:100. After removing the dry polymer and 
nanoparticles from the freezer and equilibrating them at room temperature, samples were 
prepared using these ratios by mixing them in deionized water. Control samples were also 
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prepared by mixing 1500 kDa HA polymer in deionized water at different concentrations 
(1.05%, 0.7%, and 0.35% w/v). 
 
4.2.2.2.2. Using HA nanoparticle formulations at different 
concentrations 
 To evaluate the effect of nanoparticle concentration on the viscosity and 
viscoelasticity of HA nanoparticle suspensions, nanoparticles made of 1500 kDa HA 
were mixed at 1.4%, 5%, 10%, and 15% w/v concentrations with deionized water. 1500 




4.2.2.2. Viscosity measurement 
 To investigate the viscosity of samples made in sections 4.2.2.1.1. and 4.2.2.1.2., 
an AR 2000 rheometer (TA Instruments, Delaware) equipped with a 2°, 20 mm diameter 
cone-plate at 25 °C was employed. Similar to section 3.2.2.7., after loading samples 
under the rheometer, shear stress and viscosity of the samples were measured over a a 




4.2.2.3. Viscoelasticity measurement 
 To evaluate the viscoelasticity of samples prepared in sections 4.2.2.1.1. and 
4.2.2.1.2., dynamic oscillatory rheological measurements were performed using an AR 
2000 rheometer (TA Instruments, Delaware) equipped with a 2°, 20 mm diameter cone-
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plate at 25 °C. Similar to section 3.2.2.6., first, strain sweep experiments were performed 
to determine the limit of viscoelasticity, where the rheological properties are strain 
dependent. Then, the viscoelastic properties of colloidal suspensions were evaluated 
using a frequency sweep from 0.1 to 10 Hz at 1% strain, which was in the linear 
viscoelastic region. This range includes the physiological frequencies of the knee, 




 All formulations were prepared as described and tested to evaluate their viscosity 
and viscoelasticity (Figure 4-1). A simulated Orthovisc
® 
using a HA polymer solution 
(1500 kDa) at 1.4% w/v concentration was compared to a HA nanoparticle suspension 
(1500 kDa) at similar concentration. It was observed that the polymer solution was highly 
viscous; however, the nanoparticle suspension was more water-like. The nanoparticle 




Figure (4-1) (Left): HA polymer solution (HA-PO 1500 kDa) at 1.4% w/v concentration. 
A viscous polymer solution was observed. (Right): HA nanoparticle suspension (HA-NP 
1500 kDa) at 1.4% w/v concentration. Viscosity of the nanoparticle suspension was much 
lower than the polymer solution. 
 
4.3.1. Viscosity measurement 
4.3.1.1. Mixing HA nanoparticles with HA polymer to reach hyaluronic 
acid concentration in the Orthovisc
®
 formulation 
 The rheological behavior of HA polymer/nanoparticle mixtures using 1500 kDa 
polymer and nanoparticles made from 17 kDa or 1500 kDa HA was explored. Increasing 
nanoparticle concentration reduced the shear stress and viscosity of the 
polymer/nanoparticle mixtures independent of the HA molecular weight used for 
nanoparticle fabrication. The highest shear rate and viscosity values were observed for 
the sample with 100% HA polymer. On the other hand, the lowest shear rate and 
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viscosity values were for the samples with 100% HA nanoparticles made from either 17 
kDa or 1500 kDa HA. 
 
 
Figure (4-2) Rheological evaluation of HA polymer (1500 kDa) and HA nanoparticle (17 


























Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-100:0)-17 kDa NP
HA 1.4% 1500 kDa-(PO:NP-75:25)-17 kDa NP
HA 1.4% 1500 kDa-(PO:NP-50:50)-17 kDa NP
HA 1.4% 1500 kDa-(PO:NP-25:75)-17 kDa NP






Figure (4-3) Rheological evaluation of HA polymer (1500 kDa) and HA nanoparticle (17 






















Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-100:0)-17 kDa NP
HA 1.4% 1500 kDa-(PO:NP-75:25)-17 kDa NP
HA 1.4% 1500 kDa-(PO:NP-50:50)-17 kDa NP
HA 1.4% 1500 kDa-(PO:NP-25:75)-17 kDa NP






Figure (4-4) Rheological evaluation of HA polymer (1500 kDa) and HA nanoparticle 




























Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-100:0)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-75:25)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-50:50)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-25:75)- 1500 kDa NP




Figure (4-5) Rheological evaluation of HA polymer (1500 kDa) and HA nanoparticle 
(1500 kDa) mixtures. Increasing nanoparticle content in the formulation decreased 
viscosity. 
 
 Comparing polymer/nanoparticle mixtures made from either 17 kDa or 1500 kDa 
HA nanoparticles showed that samples containing 17 kDa HA nanoparticles had higher 
viscosity than samples made from 1500 kDa HA nanoparticles at all polymer: 
nanoparticle ratios (Figure 4-6). These results suggested that nanoparticles made from 17 
kDa HA might interact more with 1500 kDa polymer chains resulting in greater viscosity. 
This interaction might be the result of dangling chains on the surface of 17 kDa 
nanoparticles. This hairy structure might facilitate entanglement with polymer chains 
resulting in greater viscosity values compared to the samples made from 1500 kDa HA 





















Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-100:0)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-75:25)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-50:50)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-25:75)- 1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-0:100)- 1500 kDa NP
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1500 kDa HA nanoparticles might be due to inhibiting polymer chain entanglement 
between HA molecules in solution. These data could also support the formation of 
colloidal gels using 17 kDa HA nanoparticles and the formation of paste-like materials 
using 1500 kDa HA nanoparticles observed in chapter three. 
 In addition, the difference in initial viscosity of samples using 17 kDa or 1500 
kDa HA nanoparticles increased by increasing the concentration of HA polymer in the 
samples. The samples at a 75:25 ratio had the greatest initial viscosity difference 
comparing the two nanoparticle types (Figure 4-6). Increasing nanoparticle concentration 
decreased this viscosity difference as well as the overall viscosity of the samples. This 
might be due to more polymer-nanoparticle interaction and physical entanglement in the 
samples with higher polymer concentrations. Therefore, the viscosity of 
polymer/nanoparticle mixtures could be controlled using nanoparticles made from HA 
with different molecular weights. 
 Formulations containing 1500 kDa HA nanoparticles had viscosity values closer 
to the control samples at different polymer:nanoparticle ratios. Increasing the 
concentration of nanoparticles showed that the difference between the initial viscosity of 
the formulations and controls became lower. These results could suggest that the 
entanglement of free surface chains on nanoparticles was more dependent on the 
concentration of free polymer in the suspension. Moreover, the absence of sufficient 
dangling chains on 1500 kDa HA nanoparticles led to low interaction with either polymer 







Figure (4-6) Rheological evaluation of HA polymer/nanoparticle mixtures. Viscosity of 
samples made with 17 kDa HA nanoparticles was greater than the viscosity of the 
samples made from 1500 kDa HA nanoparticles at all polymer: nanoparticle ratios. 
 
4.3.1.2. Using HA nanoparticle formulations at different concentrations 
 In the previous experiment, the viscosity of suspensions made from 17 kDa and 
1500 kDa HA nanoparticles was lower than the viscosity of HA polymer solution (1500 
kDa) at 1.4% w/v. Here, the effect of increasing nanoparticle (1500 kDa HA) 





















Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-75:25)-
1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-75:25)-
17 kDa NP

























Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-50:50)-
1500 kDa NP
HA 1.4% 1500 kDa-(PO:NP-50:50)-
17 kDa NP




















Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-25:75)- 1500
kDa NP
HA 1.4% 1500 kDa-(PO:NP-25:75)-17 kDa
NP























Shear Rate (s-1) 
HA 1.4% 1500 kDa-(PO:NP-0:100)- 1500
kDa NP




nanoparticle suspensions was investigated. The formation of colloidal systems from 1500 
kDa HA nanoparticles (1.4% w/v up to 45% w/v) was presented in chapter three (Figure 
3-1). Samples at 30% w/v and 45% w/v nanoparticle concentrations formed paste-like 
materials and the rheological properties could not be measured due to high viscosity of 
these samples. Therefore, nanoparticle concentrations up to 15% w/v were used for this 
experiment (Figures 4-7 and 4-8). The rheological behavior of HA nanoparticle (1500 
kDa) samples at 1.4%, 5%, 10%, and 15% w/v concentrations were compared to HA 
polymer solution (1500 kDa) at 1.4% w/v. 
 Increasing nanoparticle concentration increased shear stress and viscosity as shear 
rate increased. These results indicated that even at 15% w/v nanoparticle concentration, 
shear stress and viscosity of the sample were still lower than the shear stress and viscosity 
of 1.4% w/v HA in solution. Nanoparticle formation not only reduced the viscosity of 
HA, but also it may also be used to increase the concentration of HA in formulations. 
Therefore, higher HA concentrations can be injected into the body with only a small 






Figure (4-7) Rheological evaluation of HA nanoparticle (1500 kDa) suspensions at 




























Shear rate (s-1) 
HA-PO-1500 kDa- 1.4% (w/v)
HA-NP-1500 kDa- 1.4% (w/v)
HA-NP-1500 kDa- 5% (w/v)
HA-NP-1500 kDa- 10% (w/v)




Figure (4-8) Rheological evaluation of HA nanoparticle (1500 kDa) suspensions at 
different nanoparticle concentrations. Increasing nanoparticle concentration increased 
viscosity. 
 
4.3.2. Viscoelasticity measurement 
4.3.2.1. Mixing HA nanoparticles with HA polymer to reach hyaluronic 
acid concentration in Orthovisc
®
 formulation 
 The viscoelastic behavior of polymer/nanoparticle mixtures using 1500 kDa 
polymer and nanoparticles made from 17 kDa and 1500 kDa HA was evaluated (Figures 
4-9 to 4-14). Increasing nanoparticle concentration lowered storage, loss, and complex 
moduli of the polymer/nanoparticle mixtures independent of the HA molecular weight 





















Shear rate (s-1) 
HA-PO-1500 kDa- 1.4% (w/v)
HA-NP-1500 kDa- 1.4% (w/v)
HA-NP-1500 kDa- 5% (w/v)
HA-NP-1500 kDa- 10% (w/v)
HA-NP-1500 kDa- 15% (w/v)
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with 100% HA polymer. In contrast, the lowest viscoelasticity was found for the samples 
with 100% HA nanoparticles made from either 17 kDa or 1500 kDa HA. 
 
 
Figure (4-9) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (17 kDa) 
mixtures: elastic modulus over frequency range. Increasing nanoparticle concentration 


















HA 1.4% (w/v)-1500 kDa-(PO:NP-100:0)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-75:25)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-50:50)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-25:75)- 17 kDa NP






Figure (4-10) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (17 kDa) 
mixtures: viscous modulus over frequency range. Increasing nanoparticle concentration 

















HA 1.4% (w/v)-1500 kDa-(PO:NP-100:0)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-75:25)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-50:50)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-25:75)- 17 kDa NP






Figure (4-11) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (17 kDa) 
mixtures: complex modulus over frequency range. Increasing nanoparticle concentration 



















HA 1.4% (w/v)-1500 kDa-(PO:NP-100:0)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-75:25)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-50:50)- 17 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-25:75)- 17 kDa NP






Figure (4-12) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (1500 
kDa) mixtures: elastic modulus over frequency range. Increasing nanoparticle 


















HA 1.4% (w/v)-1500 kDa-(PO:NP-100:0)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-75:25)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-50:50)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-25:75)- 1500 kDa NP






Figure (4-13) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (1500 
kDa) mixtures: viscous modulus over frequency range. Increasing nanoparticle 

















HA 1.4% (w/v)-1500 kDa-(PO:NP-100:0)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-75:25)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-50:50)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-25:75)- 1500 kDa NP




Figure (4-14) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (1500 
kDa) mixtures: complex modulus over frequency range. Increasing nanoparticle 
concentration decreased complex modulus. 
 
 Polymer/nanoparticle mixtures made using 17 kDa HA nanoparticles showed a 
higher elastic, viscous, and complex moduli when compared to the samples made from 
1500 kDa HA nanoparticles at all polymer: nanoparticle ratios (Figures 4-15, 4-16, and 4-
17). Similar to viscosity measurements, these results also suggested that nanoparticles 
made from 17 kDa HA might interact more with HA polymer chains in solution resulting 
in greater viscoelasticity for the samples made from 17 kDa HA nanoparticles. The hairy 
structure of nanoparticles made from 17 kDa HA might physically entangle with HA 
polymer chains resulting in greater viscoelasticity values compared to 1500 kDa HA 
nanoparticles. On the other hand, nanoparticles made from 1500 kDa HA may behave 


















HA 1.4% (w/v)-1500 kDa-(PO:NP-100:0)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-75:25)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-50:50)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-25:75)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-0:100)- 1500 kDa NP
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Formulations containing 1500 kDa HA nanoparticles had the viscoelasticity values closer 
to the control samples at different polymer:nanoparticle ratios. Increasing the 
concentration of nanoparticles decreased the difference between the viscoelasticity of the 





Figure (4-15) Viscoelasticity of HA polymer/nanoparticle mixtures: elastic modulus over 
frequency range. Elastic modulus of the samples composed of 17 kDa HA nanoparticles 
were greater than the elastic modulus of the samples made from 1500 kDa HA 
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Figure (4-16) Viscoelasticity of HA polymer/nanoparticle mixtures: viscous modulus 
over frequency range. Viscous modulus of the samples composed of 17 kDa HA 
nanoparticles were greater than the viscous modulus of the samples made from 1500 kDa 





















HA 1.4% (w/v)-1500 kDa-(PO:NP-
75:25)- 1500 kDa NP
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HA 1.4% (w/v)-1500 kDa-(PO:NP-
25:75)- 1500 kDa NP
HA 1.4% (w/v)-1500 kDa-(PO:NP-
25:75)- 17 kDa NP




















HA 1.4% (w/v)-1500 kDa-(PO:NP-0:100)-
1500 kDa NP






Figure (4-17) Viscoelasticity of HA polymer/nanoparticle mixtures: complex modulus 
over frequency range. Complex modulus of the samples composed of 17 kDa HA 
nanoparticles were greater than the complex modulus of the samples made from 1500 
kDa HA nanoparticles at all polymer: nanoparticle ratios. 
 
4.3.2.2. Using HA nanoparticle formulations at different concentrations 
 The effect of increasing nanoparticle (1500 kDa HA) concentration from 1.4% 
w/v up to 15% w/v on the viscoelasticity of the nanoparticle suspensions was also 
evaluated (Figures 4-18, 4-19, and 4-20). Increasing nanoparticle concentration increased 
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properties of colloidal suspensions could be controlled by changing the nanoparticle 
concentration in these formulations when compared to 1.4% polymer solution. 
 
 
Figure (4-18) Viscoelasticity of HA nanoparticle suspensions at different nanoparticle 
concentrations: elastic modulus over frequency range. Increasing nanoparticle 
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Figure (4-19) Viscoelasticity of HA nanoparticle suspensions at different nanoparticle 
concentrations: viscous modulus over frequency range. Increasing nanoparticle 
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Figure (4-20) Viscoelasticity of HA nanoparticle suspensions at different nanoparticle 
concentrations: complex modulus over frequency range. Increasing nanoparticle 
concentration increased complex modulus. 
 
4.4. Discussion 
 Our study showed that increasing nanoparticle concentration in 
polymer/nanoparticle mixtures (HA concentration of 1.4% w/v) reduced viscosity and 
viscoelasticity of the samples. This decrease was influenced by nanoparticles which were 
synthesized from HA with different molecular weights. The surface structure of 
nanoparticles, which was dependent on molecular weight of HA used for nanoparticle 
fabrication, might change the rheological properties of colloidal suspensions. 
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structure, seemed to have more polymer-nanoparticle interaction and physical 
entanglement in polymer/nanoparticle mixtures compared to nanoparticles made from 
1500 kDa HA. These interactions might be the reason for greater viscosity and 
viscoelasticity in the mixtures made from 17 kDa HA nanoparticles compared to the 
mixtures made from 1500 kDa HA nanoparticles at similar polymer/nanoparticle ratios. 
Rheological studies also showed that even 1500 kDa HA nanoparticles interacted with 
HA polymer influencing viscosity and viscoelasticity. This interaction depended on the 
polymer/nanoparticle ratio. At higher polymer concentrations, more physical interactions 
between nanoparticles (17 kDa or 1500 kDa) must have yielded a greater effect on 
rheological properties of samples. By increasing nanoparticle concentration in the 
formulations with 1500 kDa nanoparticles, the viscosity and viscoelasticity approached 
the viscosity and the viscoelasticity of control samples containing only polymer. 
Therefore, the rheological properties of the viscosupplements can be controlled via the 
type and the concentration of nanoparticles mixed into the formulation. 
 Application of nanoparticles to enhance rheological properties of fluids and to 
form formation of nanocomposites has been reported (11-13). One study suggested that 
the presence of a small amount of nanoparticles with large aspect ratio improved the 
fluidity of polymeric solutions under low shear rate. On the other hand, addition of a 
large amount of nanoparticles reduced the aspect ratio by aggregation and constrained 
polymer segment motion in solutions (11). Other studies also reported the application of 
inorganic nanoparticles such as clay nanoparticles in ophthalmic and otic pharmaceutical 
formulations to modify the rheological properties of the compositions to enhance the 
viscosity, flow characteristics, or lubricity of the products. The studies showed that 
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nanoparticles could enhance shear thinning behavior and fluidity (13, 14). These reports 
and others confirmed that nanoparticles can modify the rheological properties of 
solutions but the effect of surface structure of nanoparticles to control rheological 
properties of solutions has not been clearly reported. Here, the rheological properties of 
viscosupplements could be controlled via nanoparticles. Different types of nanoparticles 
(17 kDa or 1500 kDa HA) at different concentrations can be added to the 
viscosupplements to control the viscosity and viscoelasticity. 
 Moreover, increasing HA nanoparticle (1500 kDa) concentration increased 
viscosity and viscoelasticity properties (elastic and viscous moduli) of HA polymer 
solutions. Even at relatively high (15% w/v) nanoparticle concentration, the viscosity of 
the samples was lower than the control sample simulating Orthovisc
®
 (1.4% w/v HA 
solution). At higher nanoparticle concentrations (30% and 45% w/v), formation of paste-
like material was observed. Rheological measurement at these nanoparticle 
concentrations was difficult due to the high viscosity of these samples. Finally, 
nanoparticle formation not only reduced the viscosity of HA suspensions but also could 
be used to increase the total concentration of HA in the formulation. As a result, colloidal 
suspensions can be used to increase the HA concentration with a small increase in the 
viscosity of HA viscosupplements. 
 Particle fabrication is one of the techniques used to reduce the viscosity of a 
solution. Currently, crystallization, phase separation, and complexation have also been 
reported to enhance the viscosity and increase injectability of protein solutions, 
specifically monoclonal antibodies at high doses (15-19). Such particle fabrication 
approaches packed the proteins, reduced the concentration of free protein in solution, and 
132 
 
prevented interactions which typically caused an increase in viscosity. With nanoparticle 
fabrication, the viscosity of HA viscosupplements can be reduced and the injectability 
enhanced in addition to increasing the concentration of HA in formulation. 
 
4.5. Conclusion 
 In conclusion, the ability of hyaluronic acid nanoparticles to modify the viscosity 
and viscoelasticity of a simulated viscosupplement was evaluated. Increasing 
nanoparticle concentration in polymer/nanoparticle mixtures (overall HA concentration 
of 1.4% w/v) reduced viscosity and viscoelasticity of the samples. The type of 
nanoparticles (17 kDa or 1500 kDa) influenced the nanoparticle-polymer interactions and 
controlled the rheological properties of the suspensions. In addition, the viscosity of 
suspensions that included 1500 kDa HA nanoparticles was lower when compared to 
simulated viscosupplement. The viscosity of suspensions containing 15% w/v of 
nanoparticles was also lower than the viscosity of simulated viscosupplement (1.4 w/v 
HA). Therefore, nanoparticle formations not only reduced the viscosity of HA 
suspensions but facilitated an increase in the HA concentration with minimal increase in 
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Chapter 5: Conclusion and future direction 
 Hyaluronic acid (HA) is one of the major naturally occurring components of body 
tissues. Many applications of HA have emerged in medicine including tissue engineering, 
dermatological fillers, and viscosupplementation for osteoarthritis treatment. The 
cytotoxicity of crosslinking techniques for scaffold fabrication and the high viscosity of 
viscosupplements have been issues impeding the development of products from HA. 
Thus, novel HA biomaterials for tissue engineering and improved properties of 
viscosupplements are in demand. Nanotechnology can be a useful tool to achieve these 
needs. 
 The aim of this study was to synthesize HA nanoparticles and use the fabricated 
nanoparticles to develop colloidal systems for these proposed biomedical applications. 
First, nanoparticles were successfully synthesized using a technique free of an oil and 
surfactant. This technique was also used to synthesize nanoparticles from other 
biomaterials such as chondroitin sulfate (CS). The size and charge of nanoparticles 
polymer type (HA or CS) depended on polymer concentration, HA molecular weight, 
reaction time, and the ratio of polymer to crosslinker. These factors may be optimized to 
reach a desired nanoparticle size and charge. 
 In the future, this nanoparticle fabrication technique should be tested to make 
nanoparticles from other polymers. This technique may be suitable to fabricate positively 
charged nanoparticles from polycations such as chitosan and poly-L-lysine. To synthesize 
nanoparticles, polycations primary amine groups can be crosslinked using a molecule 
such as an adipic acid crosslinker activated via carbodiimide reagents. Such nanoparticles 
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can be used to develop colloidal gels via electrostatic interactions with negatively 
charged nanoparticles. 
 HA and CS nanoparticles were also used to develop colloidal systems. The 
concentration of nanoparticles, type of nanoparticles and molecular weight of HA used 
for nanoparticle fabrication, effected the bulk properties of colloidal gels or colloidal 
suspensions. Colloidal gels are stable 3-D networks made from nanoparticles; in contrast, 
colloidal suspensions easily flow by applying shear force. Colloidal gels were formed by 
mixing 17 kDa HA nanoparticles in deionized water at 15%, 30%, and 45% w/v 
nanoparticle concentrations. On the other hand, mixing 17 kDa HA nanoparticles at 5% 
w/v concentration or 1500 kDa HA nanoparticles at concentrations up to 15% w/v 
concentration led to colloidal suspensions. Moreover, 1500 kDa nanoparticles at 30% and 
45% w/v yielded of paste-like materials. CS nanoparticles could only formed colloidal 
suspensions, even at high nanoparticle concentrations (60% w/v). 
 The formation of colloidal gels resulted from the physical entanglement of surface 
chains between nanoparticles. Using 17 kDa HA seemed to yield dangling chains or 
‘hairy’ nanoparticles. As a result, 17 kDa HA nanoparticles formed stable colloidal gel 
networks in deionized water at 15%, 30%, and 45% w/v. Colloidal gels swelled in an 
excess of deionized water or 0.1 M PBS, but did not dissociate. On the other hand, 
colloidal gels did not form when using 1500 kDa nanoparticles probably due to the 
absence of dangling chains on these nanoparticles. 
 Nanoparticle concentration influenced Young’s modulus, shear modulus, 
viscoelasticity and viscosity of colloidal gels. Mechanical testing also suggested that the 
pH and ionic strength of buffer used for colloidal gel fabrication affected Young’s 
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modulus and shear modulus of colloidal gels at different nanoparticle concentrations. 
However colloidal gels were elastomeric materials, they did not behave as an ideal neo-
Hookean elastomer. Recoverably experiments showed that the samples could recover 
their initial shape after removing external force. Recovery was observed in both 
mechanical and rheological experiments performed to evaluate shape recoverability and 
viscosity recoverability. Finally, colloidal gels could be reformed after destruction. 
 This novel colloidal gel should be tested for tissue engineering applications in the 
future. HA colloidal gels self-assemble to form a stable 3-D biomaterial without any 
chemical reaction. Testing these colloidal systems in the presence of live cells will help 
to understand the potency of these biomaterials for scaffold fabrication. Different types of 
cells including chondrocytes and fibroblasts should be used. Mechanical and rheological 
characterizations in the presence of cells will also define the effect of biological 
environment on the properties of colloidal gels. Moreover, in vivo studies will identify 
the performance of these novel biomaterials as a means to generate specific tissues such 
as cartilage and skin in the body. Injectability of colloidal gels as a function of 
nanoparticle concentration, pH and ionic strength should be investigated in future to 
enhance the viscosity of the colloidal gels for injection and develop injectable scaffolds. 
 Rheological characterization of colloidal suspensions showed that the viscosity 
and viscoelasticity could be controlled. Generally, the viscosity and viscoelasticity of HA 
formulations could be reduced by including nanoparticles in place of polymer HA. The 
polymer: nanoparticle ratio and type of nanoparticles (17 kDa HA or 1500 kDa HA 
nanoparticles) were used to control the viscosity and viscoelasticity of HA formulations 
by influencing nanoparticle-polymer interactions. Moreover, higher concentration of HA 
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could be delivered with lower viscosity when using nanoparticles in place of HA 
polymer, which makes colloidal suspensions more convenient for injection. 
 The application of colloidal suspensions to enhance the properties of 
viscosupplements including dermal fillers and intra-synovial viscosupplements should be 
explored. Polymer solutions at 1.4% w/v of 1500 kDa HA were used as a model 
viscosupplement to evaluate the effect of nanoparticles on the viscosity and 
viscoelasticity of HA formulations. In vivo studies will help us define performance of 
modified viscosupplements containing HA nanoparticles to remove skin wrinkles and 
increase treatment duration upon administration subcutaneously. Moreover, intra-
synovial injection of modified viscosupplements containing HA nanoparticles will 














Figure (A-1) Carbodiimide chemistry for peptide bond formation. EDC activates 
carboxyl groups available on molecule (1) and provide reactive intermediates (O-
acylisourea derivatives, extremely short-lived) which reacts with primary amine of 






Figure (A-2) (A and B) Stress-strain function curves for 30% (w/v) colloidal gel samples 
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Figure (A-3) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (17 kDa) 
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Figure (A-4) Viscoelasticity of HA polymer (1500 kDa) and HA nanoparticle (1500 
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Figure (A-5) Viscoelasticity of HA polymer/nanoparticle mixtures: tan delta over 
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